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Abstract: The Pictet-Spengler reaction (P-S) is one of the most direct, efficient, and variable synthetic
method for the construction of privileged pharmacophores such as tetrahydro-isoquinolines (THIQs),
tetrahydro-β-carbolines (THBCs), and polyheterocyclic frameworks. In the lustro (five-year period)
following its centenary birthday, the P-S reaction did not exit the stage but it came up again on limelight
with new features. This review focuses on the interesting results achieved in this period (2011–2015),
analyzing the versatility of this reaction. Classic P-S was reported in the total synthesis of complex
alkaloids, in combination with chiral catalysts as well as for the generation of libraries of compounds
in medicinal chemistry. The P-S has been used also in tandem reactions, with the sequences including
ring closing metathesis, isomerization, Michael addition, and Gold- or Brønsted acid-catalyzed
N-acyliminium cyclization. Moreover, the combination of P-S reaction with Ugi multicomponent
reaction has been exploited for the construction of highly complex polycyclic architectures in few
steps and high yields. The P-S reaction has also been successfully employed in solid-phase synthesis,
affording products with different structures, including peptidomimetics, synthetic heterocycles,
and natural compounds. Finally, the enzymatic version of P-S has been reported for biosynthesis,
biotransformations, and bioconjugations.
Keywords: Pictet-Spengler; tetrahydroisoquinoline; THIQ; tetrahydro-β-carboline; THBC; alkaloid;
total synthesis; natural products; cascade reaction; multicomponent reaction
My chameleon soul
Keeps turning me around
(A. Alexopoulos)
1. Introduction
Few years ago, we celebrated in a paper [1] the long-lasting presence on stage of the
Pictet-Spengler (P-S) cyclization as one of the most direct, efficient, and variable synthetic method for
the construction of important privileged pharmacophores, such as tetrahydroisoquinolines (THIQs),
tetrahydro-β-carbolines (THBCs), and polyheterocyclic architectures embodying them.
In the Act I of this tribute [1], we put in evidence some facets of the reaction, from the link to
the biogenetic pathways of natural products, mainly alkaloids, to the challenge of the stereochemical
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outcome. Moreover, we highlighted the modifications of parameters and constituents that were
employed to improve the reaction:
1. The reactivity of either nucleophile or electrophile was increased, the first by acylation of the
Nb nitrogen [2] and the second by the presence of electron donating groups on the aromatic
system [3].
2. The reaction rate was modified by changes in the reaction conditions [4,5].
3. The stereoselectivity was influenced by condensation with chiral carbonyl derivatives [6] or by
the use of internal [7] or external devices [8].
4. The enantioselectivity was improved by the intervention of a chiral catalyst [9,10].
The P-S reaction essentially relies on the formation from indolylethylamine 1 and a carbonyl
compound 2a through an intermediate 3a of the ene-iminium ion 4 tethered to an electrophilic system.
The iminium ion 4, under a nucleophilic attack, originates an annulated tetrahydropyridine moiety 5
(Scheme 1, up). Nielsen and coworkers proposed an alternative synthesis of THBCs using instead of the
classical P-S addition of an active carbonyl, which is a more convenient “aldehyde free” methodology:
the protagonist N-acyliminium ion 4 was now created by the metal-catalyzed shift of a double bond in
allylic amines 3b (Scheme 1, down). Ru(PCy3)(MPI)(PM)Cl2 (Ru alkylidene catalyst) and Rh(PPh3)Cl
(Wilkinson’s catalyst) were identified as the most efficient catalysts by a reduction of the loading to
0.1 mol % [11].
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It should be noted Gholamzadeh recently published a relevant chapter of a book, analyzing the
versatility of P-S reaction in the construction of heterocyclic scaffolds [12]. Moreover, Kumar and
coworkers published in 2018 a review depicting an overview on synthetic versus enzymatic P-S
reaction [13].
2. Variations on the Classic Pictet-Spengler Reaction
The Nielsen procedure is an example of the chameleonic versatility of P-S reaction [1]. For instance,
Magnus and coworker employed the P-S methodology to access the indole C-7 position for
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the preparation of the benzodiazepine tricyclic fragment 7, starting from commercially available
5-fluoroindoles 6 (Scheme 2). Compound 7 was the precursor of the synthesis of the bis-arylmaleimide
8, a glycogen synthase kinase-3 (GSK-3) inhibitor, in 33% overall yield [14].
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synthesis (Scheme 4 up), we might combine the Bischler–Napieralsky reaction [18], which provides 
the 3,4-dihydroisoquinoline 13a from arylethylamide derivative 12a through the pathways A or B, 
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intramolecular allylic amidation of derivative 12b to provide the tetrahydroisoquinoline 14b 
through the pathway D (Scheme 4 down) [21,22]. 
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Finally, the novel Lewis-acid catalyzed [3 + 3]-annulation process for the synthesis of THBCs
5a and THIQs 14c from sulfonyl aziridines 18 and readily available benzylic alcohols 19a and 19b
(Scheme 6), can be a valuable complement to the more widely used Pictet-Spengler condensation [25,26].
In spite of a fierce competition, the P-S cyclization maintains the role of a protagonist, enriching
the chemical literature with examples of its versatility. If we take into consideration for an update the
five years (2011–2015) following the one-century birthday, we can highlight that the reaction is still
active in the syntheses of biologically relevant benzoannulated nitrogen heterocycles.
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3. Update (2011–2015) of Pictet-Spengler Reactions
I think it’s time
To do an update
(Roger Turner)
3.1. Tetrahydroisoquinolines and Tetrahydro-β-Carbolines
Several substituted THIQ [27–40] and THBC [41–64] have been designed, synthesized via P-S
cyclization, and evaluated for their biological activities. The list comprehends aminopeptidase N (APN)
inhibition [27], multidrug resistance reversal effect [28], cytotoxicity against K562 [29], non-saccharide
activators of antithrombin [31], anticoagulants [32], microtubule disruptors for antiproliferative
activity [33,34], cytotoxicity against MOLT-3 [35] or HepG2 [36] cell lines, and the inhibitory activity
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towards cisplatin-insensitive cell line Skov3 [37] or the growth of Mycobacterium tuberculosis [39] for
THIQ. For THBC, the inhibition of topoisomerase II [41], the oncogenic RAS-lethality [47], and the
antimalarial activity of spirocyclic structures [44–46,56,60] were the most studied biological properties.
Chiral catalysts derived from BINOL [40,44,45] and SPINOL [49] (phosphoric acids and
thiourea derivatives) stand out among the usual Brønsted acids: TFA [35,42,47,57], HCl [58],
1,1,1,3,3,3-hexafluoro-2-propanol (HFIP) [59], 2,4,6-trichloro-1,3,5-triazine (TCT) [54], H2SO4 [50],
MeSO3H [52], TsOH [58], and mild catalysts, such as phosphate buffer [30,39] and microwave
irradiation [61].
N-substituted aryl ethylamines 20 [27,31,35,36,39,40], allene-containing-tryptophan 21 [42],
trifluoromethylated precursors 22 [55], and spirocyclic lactams embodying Trp 23 [56] were
the most interesting amine substrates. Conversely, isatins 24 [44–46], enaminone 25 [52],
(S)-2,3-O-isopropylidene-L-glyceraldehyde 26 [53], pyridoxal 27 [60], L/D-amino aldehydes 28 [57,63],
and 11C-labeled formaldehyde 29 [58] were the most notable carbonyl components (Figure 1).
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We wish to highlight few papers concerning the P-S cyclization of THIQs [32–36] and THBCs 
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Figure 1. Amine (20–23) and carbonyl (24–29) substrates of P-S reactions, leading to tetrahydroisoquinolines
(THIQs) and THBCs.
We wish to highlight few papers concerning the P-S cyclization of THIQs [32–36] and
THBCs [38,43,51,55]. In the first one, the authors described three complementary high yielding
syntheses of electronically rich 1,2,3,4-tetrahydroisoquinoline-3-carboxilic acid (THIQ3CA) esters 33,
which were based on glycine donors including hydantoin Pr-a, (±)-Boc-α-phosphonoglycine trimethyl
ester Pr-b, and (±)-Z-α-phosphonoglycine trimethyl ester Pr-c (Scheme 7). Following this approach,
a focused library of N-arylacyl, N-arylalkyl, and bis-THIQ3CA analogs 34 was synthesized [32].
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Scheme 7. Synthesis of anticoagulants by a glycine donor strategy.
Potter and coworkers developed a new series of anticancer agents by translating the key elements
of steroidal pharmacophores into alternate scaffolds. The authors synthesized 6-benzyloxy-7-methoxy
tetrahydroisoquinoline 36 via the key P-S reaction (Scheme 8, up), and then connected the steroid
A/B ring mimicking THIQ core to monomethoxybenzyl ring through methylene [33,34], carbonyl [34],
and sulfonyl linkers X [34], to provide the desired putative steroidomimetic 37. Finally, the optimization
of the representative 37 trough conformational biasing delivered a new series of microtubule disruptors
with a 10-fold gain in antiproliferative activity [33]. Linkage of the THIQ-based A/B-mimic 36 with
the trimethoxybenzyl motif that is prevalent in colchicine disclosed a series of chimeric molecules 38
(Scheme 8, down), whose activities surpass those of parent steroid derivatives [34].
Studies on the quantitative structure-activity relationship (QSAR) of N-benzenesulfonyl THIQ
analogs 41 revealed the toxicity of several compounds against MOLT-3 cell lines (Scheme 9). The sulfonyl
group was expected both to increase the electrophilicity of the iminium intermediate and to govern the
bioactivity [35,36].
The structures of N-methyl-6-hydroxy-1,2,3,4-tetrahydro-β-carboline (42) and 3,4,5,6-tetrahydro-
7-hydroxy-5-methyl-1H-azepino[5,4,3-cd]indole (cimitrypazepine, 43), which were isolated from
the root-extract of Cimicifuga racemosa (black cohosh), were confirmed by comparing the mass
fragmentations with those of P-S adducts that were synthesized by the condensation of Nω-methyl
serotonin and formaldehyde via a pH-guided nucleophilic attack to different sites (Scheme 10) [48].
Conformationally locked allene-containing THBC (not shown), which was generated from the
corresponding tryptophan derivative 21 via P-S cyclization, was subjected to cycloisomerization
reaction to give tetrahydroindolizinoindole 44a. The functionalization of 44a with an alkyne
and [2+2] cycloaddition of the allene-yne provided the tetrahydro-β-carbolinecyclobutanes 44b,
while cyclocarbonylation afforded α-methylenecyclopentenones 46d (Scheme 11) [51].
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A library of 34 THBC-containing compounds (46), including the N-tosyl derivatives 46b,
was synthesized utilizing a skeletal diversification strategy. In silico screening directed these compounds
to the appropriate biological targets [51].
A model P-S condensation of tryptophan (Trp) and [11C]formaldehyde in neutral or acidic medium
(TsOH or HCl) afforded the desired [1-11C],2,3,4-tetrahydro-β-carboline-3-carboxilic acid [1-11C]Tpi.
Analogously, Trp·HCl-containing (RGD) peptide cyclo[Arg-Gly-Asp-D-Tyr-Lys] 47 successfully gave
the labeled [1-11C]-containing RGD-peptide 48 (Scheme 12) [58].
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Some references on P-S-driven synthesis of THIQ [38,40] and THBC [43,45,53,55] have been cited
and/or discussed in other reviews [65,66].
3.2. Polyheterocycles
The THIQ/THBC motif does not only occur as a simple mono- or plurisubstituted ring system
as in salsolinol (5,6-dihydroxytetrahydroisoquinoline) or Tcc (tetrahydro-β-carboline-3-carboxilic
acid), but it can be fused with an additional five-membered (e.g., crispine A and/or harmicine) or
6-memberd ring (e.g., ISA-2011B, 1-indol-3-yl-6,7-methylenedioxy-1,2,3,4-THIQ diketopiperazine).
The construction of fused rings on the THIQ or THBC skeleton is a key step in most of the total
syntheses of natural products (isoquinoline and indole alkaloids), such as ecteinascidin 743 (ET-743)
and yohimbine (Figure 2), which will be updated in the next section (vide infra).
The additional ring can be an aromatic ring as in protoberberines 53 [67,68], a pyrrole nucleus
as in pyrroloisoquinolines (55 [69,70]) and phenanthroindolizidines (50 [71,72]), a piperazine or
a diketopiperazine fused ring, as in phenathroquinolizidines 51 [72] and THIQ analogs 65 [73].
Phenanthroindolizidines (50 [71,72]), phenanthroquinolizidines (51 [72]), tetrahydroprotoberberines
(53 [67,68]), pyrroloisoquinolines (55 [69,70]), and diketopiperazine-fused THIQs (65 [73], vide infra) embody
the tetrahydroisoquinoline skeleton, while indolizinoindoles (57 [74,75]), THBC-imidazolinediones
(59 [76]), THBC-piperazinedione (61 [77,78]), the tetracyclic indole alkaloids (S)-harmicine (pyrrole-fused
THBC, [66,79]), and (S)-eleagnine (1-methyl THBC, [66,80] represent the THBC-containing
polyheterocycles. The additional ring can be already present in the imine substrate before the P-S
reaction (type A) or can be built on the THIQ/THBC skeleton exploiting the functionality of some
substituents (type B). The concomitant ring-closures of the dihydropyridine and the additional ring are
also feasible (type C).
Palladium-catalyzed annulation of highly methoxy-substituted 2,2′-diiodobiphenyls with
alkynes provided phenanthrene derivatives 49a, 49b, and 49c, which were transformed into
Molecules 2020, 25, 414 11 of 82
phenanthroindolizidines (n = 1) 50a (R1, R3 = OMe, R2 = H) and 50b (R1, R3 = H, R2 = OMe),
and phenanthroquinolizidine (n = 2) 51 (R1, R2 = H, R3 = OMe) by a P-S reaction (Scheme 13) [71].
Conversely, 13a-methylphenanthroindolizidine (n=1) 50c (R1 = OMe, R2 = R3 = H; Scheme 13) was
obtained by an enantioselective approach, including inter alia, an efficient stereoselective Seebach’s
alkylation and P-S cyclization [72].
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The participation of a sulfinyl group in an ipso electrophilic aromatic substitution reaction was the
key step of the syntheses of (S)-(−)-xylopinine 53a [67] and successively of (S)-(−)-tetrahydropalmatine
53b and (S)-(−)-canadine 53c [68], natural products that belong to the tetrahydroprotoberberine
alkaloids class (Scheme 14).
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Sche e 14. Protoberberine alkaloids via a sulfinyl directed P-S cyclization. * indicated the different
conditions used for the reaction, reported in the bottom part of the scheme.
BINOL-derived chiral Brønsted acids catalyze the intramolecular α-amido alkylation of a tertiary
N-acyliminium ion containing a dimethoxylated phenyl ring as internal π nucleophile. The use of
sterically congested BPA-4 (see Scheme 33) was determinant in obtaining good level of enantioselectivity
for the pyrrolo[2,1-a]isoquinoline 55 (Scheme 15, up) [69].
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Novel chromeno[4,3-b]pyrroles 56 were synthesized by intramolecular 1,3-dipolar cycloaddition.
A subsequent P-S cyclization in the presence of p-TsOH yielded indolizino [6,7] indoles 57 (Scheme 15,
down). Chromenopyrroles and indolizinoindoles were both evaluated for their antimicrobial and
antioxidant activities [75].
In a type B building example, the four diastereomers (1R,3R; 1S,3S; 1R,3S; 1S,3R) of the
1,3-substituted THBC 59 were synthesized by a non-stereoselective P-S reaction to give the
corresponding hydantoin derivatives 60a–d (four diastereomers for each substituent R) by treatment
with ethyl-, butyl-, tert-butyl-, and allyl-isocyanate. Conversely, the piperazinedione polycycles 62ab
(two diastereomers from (S)-cis and (S)-trans 60) were prepared through the chloroethanone derivatives
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61ab (Scheme 16). The inhibitory activity on phosphodiesterase 5 (PDE5) of all the synthesized
compounds was evaluated by structure-activity relationship (SAR) studies [76].
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A protocol for the P-S condensation between the methyl ester of L-DOPA 63a and various N-Boc
protected 1H-indole-3-carbaldehydes 64a gave C-1 indol-3-yl substituted THIQs 66a as a mixture of
isolable cis/trans diastereomers in good yield. Following a Type-A procedure, the THIQ products 65a
can be in turn transformed into optically active diketopiperazine fused analogue 66a. Alternatively,
compounds 66b were directly prepared drom L-DOPA derivative 63b by condensation with N-Boc
protected 1H-indole-3-carbaldehydes 64b without isolation of the P-S precursors 65b (Scheme 17) [73].
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n asymmetric or racemic diastereos lective reaction afforded indole alkaloids 74 via P-S reaction
with short reaction times under solvent- and catalyst-free microwav irradiation (Scheme 19 down) [74].
3.3. Total Synthesis of Complex Alkaloid Natural Products
he two privileged nuclei, THIQ and THBC, can be embodied, even in the number of two or three
units, into the framework of polycyclic complex structures as those reported in Figure 3. The total
syntheses of structurally diverse compounds, all being endowed with a host of biological activities,
include in most cases a step overcome by P-S methodology.
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Table 1. Pictet-Spengler reaction in total synthesis of natural products.
Target Scheme/Figure P-S Carbonyl Partnerand Catalyst Note [Ref]
(±)-cribrostatin 4
(±)-renieramycin G
Scheme 20
Figure 3
(EtO)2CHCH2OBz
TMSOTf cytotoxic studies [82–85]
(±)-hamayne Figure 3 CH2O/HCO2H crinine type alkaloids [86]
(±)-lycorane Figure 3 CH2O/HCl Amaryllidaceae family [87]
(−)-saframycin A Scheme 21
OHC-CH2NHCbz
CF3CH2OH, AcOH, 4 Å
MS
intermolecular P-S (C-1)
intramolecular
P-S (C-11)
[88]
mitragynine,
paynantheine,
speciogynine
Scheme 22 Aldehyde 80Thiourea-derived catalysts
Mitragyna yohimbinoid
alkaloids [89]
(±)-tangutorine Scheme 23 Aldehyde 83micRowave
the same cytotoxic activity
for racemate and pure
enantiomers
[90]
(−)-lemonomycin Figure 3 CinnamaldehydeCSA, TMSCN
potent activity against
drug-resistant cocci [91]
tetracyclic core of
lemonomycin Figure 3
OHC-CO2Et
CF3CH2OH, AcOH,
4 Å MS
substrate-induced
stereocontrol strategy [92]
venenatine
alstovenine Scheme 24
Compound 86
HCl (aq) oR DMAP oR
NaI
yohimbinoid alkaloids
C-3 stereochemistry [93]
3-arylacrilamide
(C-1)-side chain
derivatives
Figure 3 OHC-CH2NHCbzNaOAc/AcOH
saframycin/ecteinascidin
type compounds [94,95]
(+)-lochnerine
(+)-dispegatrine Figure 3
OHC(CH2)2CO2Me
AcOH sarpagine type [96]
(−)-jorunnamycins A, C
(−)-jorumycin Scheme 26
Compound 89
CF3CH2OH, AcOH
renieramycin type [97]
(−)-renieramycin G Scheme 26 Compound 89CF3CH2OH, AcOH
renieramycin type [98]
(±)-alstonerine Scheme 25 Compound 91Wet CH2Cl2
macroline/sarpagine type [99]
erysotramidine Scheme 25 Compound 93H3PO4
erythrina alkaloids [100,101]
(±)-actinophyllic acid Scheme 27 Different form of P-S indolohydroazocine [102]
cribrostatin 4
renieramycin I Scheme 28
(EtO)2CHCH2OBz
TMSOTf/Ac2O
synthesis of left-half
renieramycin model
compound
[103,
104]
(+)-yohimbine Figure 3 Reported in [65] - [105]
(−)-corynantheidine Figure 3 Reported in [65] corynanthe alkaloids [106]
(−)-corynantheine
(−)-dihydrocorynantheine Figure 3 Reported in [65] corynanthe alkaloids [107]
(−)-affinisine oxindole Figure 3 Reported in [66] - [108]
(2011) Cyclization of 3-arylidene-6-methylpiperazinedione 75 with 2,2-diethoxyethyl benzoate
afforded in two steps the P-S-adduct 76 as a single isomer (Scheme 21). The lactam 76 was used to
construct the pentacyclic key intermediate framework (not shown) [82] and achieve the total synthesis
of cribrostatin 4 [83] and renieramycin G (Figure 3) [84,85].
• in the total synthesis of (±)-hamayne (Figure 3) the C-1 methylene was introduced via a P-S
reaction at the end of 13 steps, just before deprotection of hydroxyl groups [86];
• the total synthesis of γ-licorane (Figure 3) was also completed by a P-S ring closure [87]; and,
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• the asymmetric total synthesis of (−)-saframycin A (Scheme 20) from L-tyrosine involved
stereoselective intramolecular and intermolecular P-S reactions to induce the correct
stereochemistry at C-1 and C-11, respectively [88].
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(2012) The key intermediate 81, containing the THBC ring of mitragynine, paynantheine, and
speciogynine (Scheme 22), was constructed via an enantioselective thiourea-catalyzed P-S cyclization
involving the tryptamine derivative 79 and the aldehyde 80 [89].
• Aldehyde 83, as obtained from protected glutaraldehyde, is condensed with tryptamine
(P-S reaction, TFA) to form the pentacyclic THBC 84, a precursor of tangutorine (Scheme 23) [90].
• A thermodynamically controlled P-S reaction for the formation of the tetrahydroisoquinoline
skeleton is among the steps that lead to the efficient and convergent total synthesis of
(−)-lemonomycin (Figure 3) [91].
(2013) The tetracyclic core of lemonomycin (Figure 3) was synthesized from a known substituted
tyrosinol through a 16-step sequence, which involved the P-S reaction inter alia [92].
In the first total syntheses of C-3 epimeric natural products venenatine and alstovenine (Scheme 24),
the stereochemistry at C-3 of the yohimbinoid skeleton was effectively controlled in a P-S cyclization
utilizing an aminonitrile intermediate [93].
• 24 compounds with diversified 3-aryl acrylic amide side chains of the simplified
saframycin-ecteinascidin pentacyclic skeleton (Figure 3) were synthesized via a stereospecific
route, starting from L-DOPA [94,95].
• In the framework of the synthesis of indole alkaloids such as the monomers (+)-locknerine,
(+)-spegatrine, and the dimer P-(+)-dispegatrine (Figure 3), the mixture of cis/trans products from
the P-S reaction was converted by treatment with TFA into the desired trans isomer [96].
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(2013) O-Triflation of indolyl derivative 90, followed by the addition of DIBAL-H and wet
Et2O-Rochelle salt w rk-up, gave th crude hemiaminal lactol, which, after quick treatme t with
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ester 91. The removal of the N-tosyl group and N-methylation of 91 ended a concise synth sis of the
macr line-related alkaloid (±)-alstonerine (Scheme 26, up) [99].
Molecules 2020, 25, 414 22 of 82
Molecules 2020, 25, x FOR PEER REVIEW 24 of 84 
 
Scheme 26. P-S cyclization as a key step in the synthesis of (±)-alstonerine (up) and erysotramidine 
(down). 
(2014) The key steps of the synthesis of erysotramidine included two oxidative 
dearomatization processes that were mediated by a hypervalent iodine reagent, a novel tandem 
aza-Michael rearomatization, a P-S cyclization (9293) to produce the main tetracyclic system and 
the final stereoselective ketone reduction (Scheme 26, down) [100,101]. 
(2014) In a P-S type reaction, the electrophile 94 and the π-nucleophile 95 gave the tetracyclic 
intermediate 96, which can be converted into the pentacyclic precursor 97 of the total synthesis of 
the indole alkaloid (±)-actinophyllic acid (Scheme 27) [102]. 
 
Scheme 27. Lewis acid catalyzed cascade: key step in the total synthesis of (±)-actinophyllic acid. 
(2014–2015) Saito and coworkers presented an alternative large-scale approach for the total 
synthesis of cribrostatin four analogs, as well as C3-C4 unsaturated bis-p-quinone derivatives, such 
as renieramycin I. According to the results of previous studies [103], the treatment of the readily 
Sche e 26. P-S cyclization as a key step in the synthesis of (±)-alstonerine (up) and erysotra idine
(down).
(2014) The key steps of the synthesis of erysotramidine included two oxidative dearomatization
processes that were mediated by a hypervalent iodine reagent, a novel tandem aza-Michael
rearomatization, a P-S cyclization (92→93) to produce the main tetracyclic system and the final
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(2014) In a P-S type reaction, the electrophile 94 and the π-nucleophile 95 gave the tetracyclic
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(2014–2015) Saito and coworkers presented an alternative large-scale approach for the total
synthesis of cribrostatin four analogs, as well as C3-C4 unsaturated bis-p-quinone derivatives, such as
renieramycin I. According to the results of previous studies [103], the treatment of the readily available
compound 98 with trimethylsilyl chloride (TMSCl) in DCM in the presence of triethylamine afforded
lactam intermediate 99, which, in turn, treated with 2,2-diethoxyethyl benzoate in the presence of
trimethylsilyl triflate (TMSOTf) and Ac2O gave the P-S product 100 as a diastereomeric mixture
(a/b: 10/3) in 92% yield (Scheme 28) [104]. The conversion of the diketopiperazine THIQ 100 into
unsaturated compound 101 was the first key step of the synthesis of renieramycin I and cribrostatin 4
(Figure 3) through the intermediate 76 (see Scheme 21).
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(2011) The P-S reaction got a lead role in the total syntheses of (+)-yohimbine [105],
(−)-corynantheidine [106,107], (+)-corynantheine, and (+)-dihydrocorynantheine [107] (active as
antimicrobial against Staphylococcus aureus-induced infections [109]), which have been reviewed in
Todd’s paper [65]. Analogously, the total synthesis of (−)-affinisine oxindole [108] was reported
previously in the paper of Dalpozzo [66].
4. Dressing with Fashionable Clothes a Classic Reaction
Not to be old fashioned
I’ll put something red
(Emily Dickinson)
I the second century on stage, the P-S cyclization maintains its peculiar chameleonic quality, but
to remain at the lim light needs to join the forces with in-fashion allies, such as t e support of solid
phases, the pus of new catalysts, and mainly the impuls of new habits, such as the casc de s quences
and the multicomponent reactions (MCRs).
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4.1. A New Scenography: Updating the Solid Phase Strategy
Advances in support, protecting group strategies, and extensive optimization of chemical
methodology have expanded the scope of solid phase chemistry from mere peptide preparation to
the synthesis of pharmacologically relevant small molecules [110–112], as well as the total synthesis
of natural products and their analogues [113,114]. Different versions of P-S reaction have found
application in a procedure, where the solid-phase support can be chosen to modulate the reactivity of
the three functional groups (aldehyde, amine, and aromatic nucleophile) [115].
In 2009, a paper from Nielsen et al. reviewed the methods used to generate N-acyliminium
ion intermediates on solid support and gain access via the intra- or intermolecular P-S condensation
products to diverse structures [116].
Meldal and coworkers focused on solid phase variants of the P-S reaction as rich sources for
the construction of polyheterocyclic scaffolds. The authors synthesized pyrroloisoquinolines [117],
bicyclic dipeptide mimetics [118], and polycyclic compounds containing THIQ, THBC, or analogous
motifs [119]; they successfully applied the methodology to the formation of a range of (5,6,5)-, and
(6-6-5)-fused heterotricyclic ring systems [120].
In the 2011–2015 year range, only two papers concerning an approach in solid phase of the
intramolecular P-S reaction appeared [121,122]. In the first one by Chanda et al., polyethylene
glycol-immobilized tryptophan ester 102 was combined with a variety of ketones by reflux in
acidic chloroform, to give soluble polymer-supported THBCs in good yields [121]. Amination of
the Nb-chloroacetamide that was obtained by treatment with chloroacetyl chloride, followed by
intramolecular cyclization and cleavage of the polymer, finally led to the costruction of a tetracyclic
architecture. The reactions and the following synthesis of biologically promising diketopiperazine-fused
THBC structures 103 are resumed in Scheme 29 [121].
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treatment with a mild acid (HCOOH, the more efficient after a screening), generate the N-
akyliminium ions, which undergo P-S type cyclization (Scheme 30) [122]. The cascade sequence 
afforded in a high stereoselective fashion pure products 106 after cleavage from the resin. The 
combination of various γ-ketoacid amides with a range of nucleophiles, including electron-rich 
aromatic (as 3,4-dimethoxy substitution for 106a) and heteroaromatic rings (as indole nucleus for 
106b), led to a library of a range of pharmaceutically interesting heterocyclic scaffolds with 
exclusive diastereocontrol of the junction stereocenters [122]. 
Scheme 29. Synthesis of diketopiperazine-fused THBCs on soluble polymer support.
Another process (by Nielsen et al., 2012) relies on an efficient ketone-amide condensation, starting
fromγ-ketocarboxylic acids, immobilized on a solid support as 104. Substrates, by treatment with a mild
acid (HCOOH, the more efficient after a screening), generate the N-akyliminium ions, which undergo
P-S type cyclization (Scheme 30) [122]. The cascade sequence afforded in a high stereoselective fashion
pure products 106 after cleavage from the resin. The combination of various γ-ketoacid amides with
a range of nucleophiles, including electron-rich aromatic (as 3,4-dimethoxy substitution for 106a)
and heteroaromatic rings (as indole nucleus for 106b), led to a library of a range of pharmaceutically
interesting heterocyclic scaffolds with exclusive diastereocontrol of the junction stereocenters [122].
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(2011) The Nielsen group developed the synthesis of indolizinoindoles 110, starting from the 
ruthenium alkylidene catalyzed tandem ring closing metathesis (RCM) of dienes 107 via N-
acyliminium intermediates 109 (Scheme 31, up). In the case of indole substitution (107a) and five-
membered ring (n = 0), the corresponding unsaturated lactams 108β and 108α are formed after a 
RCM and subsequent isomerization, respectively. The successive protonation or reaction of 108α 
with Ru+ gave the reactive N-acyliminium species 109, which were finally trapped by the tethered 
nucleophile to give the THBC tetracycle 110a (n = 0). The homologous indole-based substrates 107a 
(n = 1; n = 2) underwent RCM reactions, but not further conversions into THBCs, being required the 
conjugation of the double bond that formed in the RCM step with the lactam carbonyl. Hoveyda–
Grubbs catalyst HG-I (at 5 mol%, in m-xylene at reflux) gave the cleanest and highest conversion 
107a (n = 1, 2)  110a (95%; n = 1, 2). The trimethoxybenzene derivative 107c (n = 1) also underwent 
the tandem reaction sequence to provide the tetrahydroisoquinoline derivative 110c in good yield 
(64%, Scheme 31, down). By contrast, the conversion of substrate 107d or other substrates bearing a 
heterocycle moiety (not shown) required the successive addition of TFA (1 eq.) and further 2 h 
heating to give the tricycle product 110d (or the other corresponding cyclization products) in 98% 
yield and diastereomeric ratio > 20:1, or the other cyclization products [123]. 
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4.2. Ruthenium-Catalyzed N-Acyliminium Cyclization
(2011) The Nie sen group developed the synthesis of indolizinoindoles 110, starting from the
ruthenium alkylidene catalyzed tandem ring closing metathesis (RCM) of dienes 107 via N-acyliminium
intermediates 109 (Scheme 31, up). In the case of indole substitution (107a) and five-membered ring
(n = 0), the corresponding unsaturated lactams 108β and 108α are formed after a RCM and subsequent
isomerization, respectively. The successive protonation or reaction of 108α with Ru+ gave the reactive
N-acyliminium species 109, which were finally trapped by the tethered nucleophile to give the THBC
tetracycle 110a (n = 0). The homologous indole-based substrates 107a (n = 1; n = 2) underwent RCM
reactions, but not further conversions into THBCs, being required the conjugation of the double bond
that formed in the RCM step with the lactam carbonyl. Hoveyda–Grubbs catalyst HG-I (at 5 mol%,
in m-xylene at reflux) gave the cleanest and highest conversion 107a (n = 1, 2)↓110a (95%; n = 1, 2).
The trimethoxybenzene derivative 107c (n = 1) also underwent the tandem reaction sequence to
provide the tetrahydroisoquinoline derivative 110c in good yield (64%, Scheme 31, down). By contrast,
the conversion of substrate 107d or other substrates bearing a heterocycle moiety (not shown) required
the successive addition of TFA (1 eq.) and further 2 h heating to give the tricycle product 110d
(or the other corresponding cyclization products) in 98% yield and diastereomeric ratio > 20:1, or the
other cyclization products [123].
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(2012) As disclosed earlier, Nielsen and coworkers performed the metal-catalyzed 
isomerization of N-acyl-N-allyl tryptamines that were previously described (Scheme 32, down) 
[124]. 
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(2012) As disclosed earlier, Nielsen and coworkers performed the metal-catalyzed isomerization
of N-acyl-N-allyl tryptamines that were previously described (Scheme 32, down) [124].
(2013) In a third step, ruthenium hydride RuHCl-(CO)(PPh3) was found as an effective promoter
of the isomerization 111β↓111α since the Wilkinson’s catalyst [124] was no more efficient for the
isomerization of the double bond of acylated allylamines 111. The combination of the ruthenium
catalyst (10% mol) together with the chiral phosphoric acid (PhO)2PO2H (30% mol) proved to be the
most efficient for the transformation of the allylic amides 111ab into THBCs 112ab, but high temperature
(toluene at reflux) was needed for the completion of the reaction. Finally, the cyclic allylic amides
111cd, in optimized reaction conditions, gave the corresponding THBCs 112cd in 92% and 68% yields,
respectively (Scheme 32) [125,126]. The treatment of other electron-rich aromatics, such as the cyclic
allylic amides 113ab in the same conditions as before, afforded the corresponding tetrahydroisoquinoline
derivatives 114ab, which were isolated in moderate yields (49–67%, Scheme 32) [125,126]. Notably,
Nb-benzyl substituents in L-tryptophan derivatives proved to be more important than the Nb-acetyl
groups for the diastereoselectivity in a substrate-controlled version of the above tandem sequence.
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(2012) A ruthenium alkylidene complex and chiral phosphoric acid catalyzed an enantioselective
version of the RCM/isomerization/P-S cascade process (Scheme 33 up). You et al. showed that the
steric bulk of the substituent adjacent to the nitrogen in the allylic system was crucial for the
high enantioselectivity [125]. Subsequently (2013), the authors established the optimal conditions
for the reaction of N-1-naphthylmethyl protected substrate 115b: benzene as solvent, 0.5 mol%
Hoveyda-Grubbs II (HG-II) and 5 mol % SPINOL-derived phosphoric acid (R)-SPA-5 as binary catalyst,
and 4Å molecular sieves as an additive. Consequently, the yield and the ee of THBCs 117 were
considerably increased (Scheme 33) [126].
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Toda and Terada described a similar enantioselective P-S type cyclization, catalyzed by ruthenium
hydride complex and chiral phosphoric acid. Relay catalysis on protected arylethylamine 118 afforded
the protected tetrahydroisoquinoline 119 (Scheme 34). The substitution pattern (R) of the aromatic ring,
the bulky 9-anthranyl group of the chiral phosphoric acid catalyst, and the N-protecting group (PG)
were surveyed and optimized [127].
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4.3. All in One Pot 
Bond formation via the intramolecular attack of N-acyliminium ion electrophiles by π-
nucleophiles is a popular method for the construction of nitrogen-containing ring systems [128–
133]. When N-acyliminium ion cyclization reactions are incorporated into cascade sequences, which 
are powerful strategies for the one-pot production of nitrogen-containing polycyclic ring systems 
emerge. At the beginning of the XXI century, the usual procedure for the synthesis of organic 
compounds, i.e., the stepwise transformation of the individual bonds in the target molecule, was 
being substituted by more efficient processes, where the readily available reactants are converted in 
a one-pot fashion into complex molecules. By a strict definition, a cascade reaction is a process in 
which multiple bonds are formed in sequence without changing conditions, adding reagents, or 
isolating intermediates. Most of the reported cascade sequences employ a single starting material, 
containing functional groups that are strategically positioned along a chain ending with an alkene 
moiety. The reactions enable two or more bond-forming and/or -cleaving events to occur in one 
vessel, where subsequent operations result as the consequence of the functionalities that formed in 
the previous step. The definition includes the prerequisite intramolecular to distinguish this 
reaction type from a multi-component reaction (vide infra). The cascade approach might assume 
different synonyms, such as tandem, domino, or one-pot and one-flask sequence, and it is also 
defined by the features of the key event, assuming the nuance of nucleophilic, electrophilic, 
cationic, anionic, pericyclic, radical, transition-metal catalyzed, enzymatic reaction, as well as being 
described as Heck reaction. 
The main advantages of a cascade reaction in organic synthesis are given by reduction of time, 
labor, waste and resources, atom economy and the cleanliness of environmental tolerable 
procedures. Moreover, the process does not involve the workup and isolation of many 
intermediates and increases in efficiency bearing much complexity in effectively one step [128–133]. 
Pioneering papers from Padwa and coworkers connected the one-pot strategy with P-S 
chemistry [134–138]. Dixon and coworkers introduced gold (I) catalyzed reaction sequences, where 
the metal ion activates alkyne, alkene, and allene functionalities under mild conditions and at low 
catalyst loading [139,140]. For instance, the group developed a direct enantio- and 
diastereoselective condensation of tryptamines 1 with five- or six-membered-ring enol lactones 120a 
[140] or γ- and δ-keto esters 120b [141], in the presence of chiral Brønsted acids, such as (R)-BPA-1 
(10 mol%) or (R)-[H8]-BPA-1 (Scheme 33). The tetracyclic products 121 were obtained in good 
overall yields (53–99%) and moderate to high enantioselectivities (68–99% ee) (Scheme 35 up). The 
reactions were mostly run in toluene with the temperature ramp [140,141]. Notably, the 
enantioselective cascade reaction of the enol lactones was compatible with an in situ gold (I)-
catalyzed synthesis from alkynoic acids 122 [140], which had been shown to undergo P-S 
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4.3. All in One Pot
Bond formation via the intramolecular attack of N-acyliminium ion electrophiles by
π-nucleophiles is a popular method for the construction of nitrogen-containing ring systems [128–133].
When N-acyliminium ion cyclization reactions are incorporated into cascade sequences, which are
powerful strategies for the one-pot production of nitrogen-containing polycyclic ring systems emerge.
At the beginning of the XXI century, the usual procedure for the synthesis of organic compounds,
i.e., the stepwise transformation of the individual bonds in the target molecule, was being substituted
by more efficient processes, where the readily available reactants are converted in a one-pot fashion
into complex molecules. By a strict definition, a cascade reaction is a process in which multiple bonds
are formed in sequence without changing conditions, adding reagents, or isolating intermediates.
Most of the reported cascade sequences employ a single starting material, containing functional groups
that are strategically positioned along a chain ending with an alkene moiety. The reactions enable
two or more bond-forming and/or -cleaving events to occur in one vessel, where subsequent operations
result as the consequence of the functionalities that formed in the previous step. The definition
includes the prerequisite intramolecular to distinguish this reaction type from a multi-component
reaction (vide infra). The cascade approach might assume different synonyms, such as tandem, domino,
or one-pot and one-flask sequence, and it is also defined by the features of the key event, assuming the
nuance of nucleophilic, electrophilic, cationic, anionic, pericyclic, radical, transition-metal catalyzed,
enzymatic reaction, as well as being described as Heck reaction.
The main advantages of a cascade reaction in organic synthesis are given by reduction of time,
labor, waste and resources, atom economy and the cleanliness of environmental tolerable procedures.
Moreover, the process does not involve the workup and isolation of many intermediates and increases
in efficiency bearing much complexity in effectively one step [128–133].
Pioneering papers from Padwa and coworkers connected the one-pot strategy with P-S
chemistry [134–138]. Dixon and coworkers introduced gold (I) catalyzed reaction sequences, where
the metal ion activates alkyne, alkene, and allene functionalities under mild conditions and at low
catalyst loading [139,140]. For instance, the group developed a direct enantio- and diastereoselective
condensation of tryptamines 1 with five- or six-membered-ring enol lactones 120a [140] or γ- and
δ-keto esters 120b [141], in the presence of chiral Brønsted acids, such as (R)-BPA-1 (10 mol%) or
(R)-[H8]-BPA-1 (Scheme 33). The tetracyclic products 121 were obtained in good overall yields (53–99%)
and moderate to high enantioselectivities (68–99% ee) (Scheme 35 up). The reactions were mostly run
in toluene with the temperature ramp [140,141]. Notably, the enantioselective cascade reaction of the
enol lactones was compatible with an in situ gold (I)-catalyzed synthesis from alkynoic acids 122 [140],
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which had been shown to undergo P-S condensation with amine tethered π-nucleophiles 1, for the
building of architecturally complex heterocycle structures 123 (Scheme 35 down).
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After the research of Dixon et al. [139–141], several papers [147–160] nourished the gold-
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(2012) Liu and Zhang reported a gold catalysis-triggered cascade reaction, where the 
formamide 124a (indole, R = H) gave, in presence of iPrAuNTf2 or BrettPhosAuNTf2 (5 mol %, as 
catalyst) and TFA (as acid additive) in the optimized reaction conditions, the indole-fused 
hexahydroquinolizin-2-one 127a (indole as aromatic moiety, R1 = H; 82% yield) after 24 h via the 
THBC intermediate 126a (Scheme 36). Electron-rich aromatic rings, such as methoxy- and 
methylenedioxy-benzene yielded instead benzene-fused hexahydroquinolizin-2-ones 127b 
(benzene as aromatic moiety, R = OMe, OCH2O) in synthetically serviceable yields. The new 
method was applied for the succinct and stereoselective synthesis of dihydrocorynantheol and a 
formal synthesis of yohimbine (Figure 3) and β-yohimbine (β-17-OH) [147]. 
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4.3.1. Au(I)-Catalyzed N-Acyliminium Cyclization Cascade
Historically, gold(I) complexes have emerged over the last decade as powerful tools for the
synthesis of polyheterocyclic molecules. Au(I)-catalyzed reaction sequences have taken center stage
due to the metal ion’s ability to activate various functionalities under mild conditions and at low
catalyst loading. Moreover, the gold tolerance to oxygen, moisture, and many functional groups is very
high, and this makes this metal an ideal candidate for the development of tandem catalytic strategies.
The chemistry of gold-catalysis has been reviewed during the years from several papers [142–146].
After the research of Dixon et al. [139–141], several papers [147–160] nourished the gold-fashion
version of P-S cyclization in the years between 2011 and 2015.
(2012) Liu and Zhang reported a gold catalysis-triggered cascade reaction, where the formamide
124a (indole, R = H) gave, in presence of iPrAuNTf2 or BrettPhosAuNTf2 (5 mol %, as catalyst) and TFA
(as acid additive) in the optimized reaction conditions, the indole-fused hexahydroquinolizin-2-one
127a (indole as aromatic moiety, R1 = H; 82% yield) after 24 h via the THBC intermediate 126a
(Scheme 36). Electron-rich aromatic rings, such as methoxy- and methylenedioxy-benzene yielded
instead benzene-fused hexahydroquinolizin-2-ones 127b (benzene as aromatic moiety, R = OMe,
OCH2O) in synthetically serviceable yields. The new method was applied for the succinct and
stereoselective synthesis of dihydrocorynantheol and a formal synthesis of yohimbine (Figure 3) and
β-yohimbine (β-17-OH) [147].
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Scheme 36. Gold catalysis-triggered cascade en route to bicyclic piperidine-4-ones.
(2013) The Dixon group developed a high enantioselective N-sulfonyliminium cyclization cascade,
which provided complex and unusual sulfonamide scaffolds in excellent yield [148]. Treatment with
Echavarren catalyst (EC-1, 10 mol% [149,150]) of a mixture of sulfonamide 128a (R = H) and BPA-1
(10 mol%) in toluene at 60 ◦C afforded the cascade product 129a (R = H) in 84% yield and 88% ee
(Scheme 37). The choice of sulfonamide over carboxylic acid amide was influenced by their abundance
in medicinally relevant compounds and the lack of sulfonamide scaffolds via cyclization cascade.
The versatility of the new methodology was verified on the chain extended amide analogue 130,
which was given by reaction cascades with EC-1 (0.5–1 mol%) and (R)-BPA-1 (10 mol%) in toluene at
reflux the desired δ-lactams 131 in 86% yield and 66% ee (Scheme 38) [148].
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The treatment of substituted tryptamines 1 and 2-ethynylbenzoic acids 132a (n = 0) or
2-ethynylphenyl acetic acids 132b (n = 1) by an efficient, facile gold(I)-catalyzed one-pot cascade
protocol featured the formation of polycyclic privileged structures 133 with high yield and broad
substrate tolerance (Scheme 39). Selected target molecules 134, which were obtained after reduction,
were validated as α1-adrenergic receptor antagonists [151].
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A P-S-type reaction was invoked for the final aromatic 1,7-cyclization step in the proposed 
mechanisms of gold(I)-catalyzed [5 + 2] cycloaddition of propargyl esters or acetals with imines (not 
shown), leading to benzo-fused azepine derivatives [152]. 
(2015) Waldmann and coworkers proposed a reaction sequence, where, in a first step 
acetylenic aldehydes 135 and tryptamine, yielded in a P-S reaction THBCs endowed with an alkyne 
substituent, which could be given via a hydroamination reaction the indoloquinolizine (IQZ) 
scaffold. Actually, microwave heating (120 °C) of a mixture of tryptamine (1a, R = H) and o-2-
phenylethynyl benzaldehyde (135a, R1 = Ph) in DCM with 10 mol% of Yb(OTf)3 after the addition of 
the ionic liquid [bmim]Cl-AlCl3 provided the THBC 136 (R = H, R1 = Ph; 74% yield) within one hour 
(Scheme 40) [153]. However, the second step, i.e., the hydroamination reaction of the P-S adduct, 
did not occur in the presence of ytterbium complexes [154,155]. By contrast, after a survey of 
selected gold complexes, the catalyst EC-1 (10 mol%) (Scheme 37) gave, at room temperature, the 
desired IQZ 137a (R = H, R1 = Ph; 62%). The authors explored the utility of the two-step protocol for 
the synthesis of hexacyclic indoloquinolizines, where a spirooxindole ring system is fused to a 
THBC moiety. Tryptamines 1 and isatins 138 afforded the hexacyclic heterocycle 139 (Scheme 41) 
[153]. 
Scheme 39. Gold(I)-catalyzed one-pot cascade for the synthesis of α1A -AR antagonists.
A P-S-type reaction was invoked for the final aromatic 1,7-cyclization step in the proposed
mechanisms of gold(I)-catalyzed [5 + 2] cycloaddition of propargyl esters or acetals with imines
(not shown), leading to benzo-fused azepine derivatives [152].
(2015) Waldmann and coworkers proposed a reaction sequence, where, in a first step acetylenic
aldehydes 135 and tryptamine, yielded in a P-S reaction THBCs endowed with an alkyne substituent,
which could be given via a hydroamination reaction the indoloquinolizine (IQZ) scaffold. Actually,
microwave heating (120 ◦C) of a mixture of tryptamine (1a, R = H) and o-2-phenylethynyl
benzaldehyde (135a, R1 = Ph) in DCM with 10 mol% of Yb(OTf)3 after the addition of the ionic liquid
[bmim]Cl-AlCl3 provided the THBC 136 (R = H, R1 = Ph; 74% yield) within one hour (Scheme 40) [153].
However, the second step, i.e., the hydroamination reaction of the P-S adduct, did not occur in the
presence of ytterbium complexes [154,155]. By contrast, after a survey of selected gold complexes,
the catalyst EC-1 (10 mol%) (Scheme 37) gave, at room temperature, the desired IQZ 137a (R = H,
R1 = Ph; 62%). The authors explored the utility of the two-step protocol for the synthesis of hexacyclic
indoloquinolizines, where a spirooxindole ring system is fused to a THBC moiety. Tryptamines 1 and
isatins 138 afforded the hexacyclic heterocycle 139 (Scheme 41) [153].
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Guinchard and coworkers used allenals 140 as bifunctional key building blocks for the synthesis
of polycyclic chiral architectures 141 (Scheme 42) in a reaction that combines an asymmetric phosphoric
acid catalyzed P-S reaction and a self-relay palladium catalyzed cyclization [56,57].
Inspired by Waldmann and Kumar [153], ending in pentacyclic derivatives 143 (Scheme 42) [158],
the authors proposed a gold-catalyzed cascade, where the P-S reaction between N-allyl tryptamines
1h and O-alkynyl arylaldehydes 142 is followed by cyclization with a concomitant allyl transfer to
give compounds 143 in good yield (Scheme 42). EC-1 (Scheme 37) was the sole catalyst for both of
the reactions. Further optimization came from the use of the stable cationic catalyst [(Ph3P)Au(NTf2)]
(EC-2), as well as molecular sieves (4Å) [158].
4.3.2. Michael Addition/Pictet-Spengler Reaction Sequences: Update 2011–2015
The combination of a base-catalyzed intermolecular Michael addition reaction—featured by
an α,β-unsaturated carbonyl compound and a suitable amide pronucleophile—with an acid-catalyzed
intra-molecular N-acyliminium ion P-S cyclization of the resulting adduct, was a quite popular cascade
sequence for building complex multiring heterocyclic molecules in one-pot and under mild conditions.
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The β-ketoester 144, cinnamic aldehyde 145a, the Michael adduct 146, and the final indoloquinolizidine
product 148 feature the sequence (Scheme 43) [159].
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same group successfully applied the cascade reaction to other nucleophiles [66,165]. 
Michael addition of trimethyl phosphonoacetate 152 to α-β-unsaturated aldehydes 145, 
catalyzed by (S)-(−)-α,α-diphenyl-2-pyrrolidinemethanol trimethylsilyl ether (Pro-A), afforded 
enantiomerically enriched adducts 153, which were employed in three different protocols leading to 
biologically important α-methylene-δ-lactones and δ-lactams. In one pathway, the indolo[2,3-
a]quinolizine scaffold 154 was accessed by the P-S reaction with tryptamine 1, followed by Horner-
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synthesis.
(2011) The Zhao group, after β-ketoesters [159] and dialkyl malonates [160], investigated alkyl
propiolates [161] and β-keto amides [162] as carbonyl partners of α,β-unsaturated aldehydes for the
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asymmetric organocatalyzed synthesis of indoloquinolizidines derivatives. By a similar pathway,
the group developed a cascade sequence between cyclic hemiacetals 150 and tryptamine 1 to provide
efficient access to highly substituted diazaindeno[2,1-a]-phenanthrenes 151. Aromatic and aliphatic
hemiacetals 150 were both prepared by the asymmetric organocatalyzed conjugate addition of cyclic
1,3-diketones to α,β-unsaturated aldehydes 145 (Scheme 44) [163].
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Sche e 44. iastereoselective cascade synthesis of indoloquinolizines.
Contemporaneously Rueping et al., developed a similar methodology for the efficient synthesis
of functionalized indolo [2,3-a]quinolizidine skeletons in a one-pot operation [164]. The same group
successfully applied the cascade reaction to other nucleophiles [66,165].
Michael addition of trimethyl phosphonoacetate 152 to α-β-unsaturated aldehydes 145, catalyzed
by (S)-(−)-α,α-diphenyl-2-pyrrolidinemethanol trimethylsilyl ether (Pro-A), afforded enantiomerically
enriched adducts 153, which were employed in three different protocols leading to biologically
important α-methylene-δ-lactones and δ-lactams. In one pathway, the indolo[2,3-a]quinolizine scaffold
154 was accessed by the P-S reaction with tryptamine 1, followed by Horner-Wadsworth-Emmons
olefination (Scheme 45) [166].Molecules 2020, 25, x FOR PEER REVIEW 39 of 84 
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The assembly by Zhu et al. of medicinally important butyrolactam-fused indoloquinolizidines
in a highly stereo-controlled organocatalytic one-pot Michael/P-S sequence has been previously
described [66,167].
Although many examples of cascade sequences that were catalyzed by a single chemical entity
have been reported [134,136], which involve more than one mutually compatible catalyst are much less
common [168,169]. With the aim of overcoming the problem of annihilation (catalyst quenching), due to
the simultaneous use of both strongly basic and strongly acidic reagents, the Dixon group employed site
isolated base and acid (SIBA) catalysis [170,171]. The group developed cascade reactions that incolve the
polymer supported 2-tert-butylimino-2-diethyl-amino-1,3-dimethyl-perhydro-1,3,2-diaza-phosphorine
(PS-BEMP) and (R)-BPA or bulky derivatives, such as (R)-BPA-1 and (R)-[H8]-BPA-1 [172]. The authors
hypothesized that the system would provide the necessary site isolation of mutually destructive acidic
and basic functional groups and a size exclusion (molecular sieving) phenomenon would operate
between PS-BEMP and (R)-BPA-1, but not between the first one and diphenyl phosphate (DPP).
The model reaction of pro-nucleophile malonamate (156a, R = H) with methyl vinyl ketone (MVK, 155a,
Molecules 2020, 25, 414 36 of 82
R1 = Me) required the following optimal conditions: PS-BEMP (10 mol%), (R)-BPA-1 (10 mol%),
the addition of MVK (3 eq) at room temperature for 24 h, N-acyliminium cyclization at reflux in toluene
for 24 h. The product 157 (R1 = H) was obtained in 81% yield and 57% ee (Scheme 46). The teatment of
a set of malonamate nucleophiles 156 with methyl vinyl ketone (MVK, 155a, R1 = Me) and ethyl vinyl
ketone (EVK, 155b, R1 = Et) in the presence of PS-BEMP and (R)-[H8]-BPA-1 investigated the scope of
the reaction. In general, yields that range from 73 to 80% and ee from 56 to 76% were achieved [172].
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Liao and coworkers reported an organocatalytic domino double-Michael/P-S/lactamization
reaction sequence leading to dodecahydrobenz[a]indolo[3,2-h]qui olizines in good yields and excellent
diaster oselectivities and enantiosel tivities (up to >99% ee). The optimizatio of the double M chael
reac ion of nitroalkenoate 158 and cin maldehyde 145a (R1 = Ph) required Pro-A as catalyst, DABCO
as additive, and DCM as solvent for 44 h reaction to give 159a (R1 = Ph) in 89% yield with 99% ee.
The one-pot reaction strategy was achieved via the addition of toluene to the reaction mixture, followed
by treatment with tryptamine 1 and TFA, to provide cyclized product 160a (R1 = Ph) in 77% yield with
>99% ee. Finally, the target products 161 were obtained after lactamization (Scheme 47). The one-pot
domino reaction protocol was repeated with various α,β-unsaturated aldehydes (R2 = Ar, 2-furyl),
obtaining high yields and stereoselectivities. The highly enantioselective transformation and the highly
functionalized pentacyclic benzoindoloquinoline products render this reaction sequence a potential
protocol for future synthetic applications of “inside α-yohimbane” intermediates [173].
Tryptamine-derived urea 162a (R1 = R2 = H) and methyl vinyl ketone 155a (MVK, R3 = Me, R4 = H)
produced the best results in toluene with BINOL phosphoric acid when the heating was increased to
110 ◦C. Catalyst screening revealed that optimal enantiocontrol was associated with (R)-BPA-1 and/or
(R)-[H8]-BPA-1 (both at 10 mol%) and optimal concentrations of substrates 162 were 5 mM (162) in the
presence of 5 eq of MVK 155a. Under these conditions, compound 165a (R = R1 = R2 = H, R3 = Me)
was obtained in 76% yield and 73% ee, through the intermediates 163 (Michael addition to the distal
nitrogen) and 164 (condensation of the ketone with tryptamine Nb) (Scheme 48). The scope of the
reaction was surveyed while using an array of substituted ureas 162 and enones 155 [174].
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Menéndez and coworkers highlighted cerium (IV) ammonium nitrate (CAN) as an excellent
catalyst for the fast synthesis ofβ-enaminones 168 [175] and performed the one-pot, efficient preparation
of 1-alkyl-6-ethoxy-1,4,5,6-tetrahydropyridines 169 from acyclic precursors, i.e., primary amines 166,
β-dicarbonyl compounds 167, α,β-unsaturated aldehydes 145, and alcohols (as sketched in Scheme 49).
The combination of this preparation with a P-S cyclization makes up a domino process that involves
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the generation of an iminium cation 170 from the tetrahydropyridines 169 and culminates in the direct
one-pot preparation of a variety of benzo[a]- or indolo[2,3-a]quinolizidines 171 [176].
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(2014) Yan et al. performed a facile synthetic procedure that involves the sequential
Michael addition and P-S reactions of β-enamino ester generated in situ. The one-pot three
component reaction of tryptamines 1, alkyl propiolates 172, and α,β-unsaturated aldehydes
155a (R = H), as well as arylidene-acetones 155b, (R = Me) afforded the functionalized
1,2,6,7,12,12b-hexahydro-indolo[2,3-a]quinolizines 173 in moderate to high yields and with high
diastereoselectivity (Scheme 50 up) [177]. Hunting for a new efficient domino reaction, the
group envisioned that spiro-indolo[2,3-a]quinolizine-oxindoles 176 could be synthesized from
a similar reaction of in situ generated β-enaminoesters 174 with oxindoles 175. However,
the domino reaction of tryptamine 1a, alkyl propiolates 172, and 3-phenacylidene-oxindoles
175 in the presence of anhydrous ZnCl2 provided, instead of the expected compound 176a,
the functionalized 2-pyrrolo-3′-yloxindoles 176b, which, in turn, can be converted into the
corresponding 6,11-dihydro-5H-indolizino[8,7-b]indoles 176c via a CF3SO3H catalyzed P-S cyclization
process (Scheme 50, down). By contrast, when arylamines replaced tryptamines 1, the one-pot domino
reaction only afforded the corresponding 2-pyrrolo-3′-yloxindoles (not shown) [178].
(2014) The first catalytic asymmetric construction of a new class of bispirooxindole scaffold
that incorporates a THBC moiety was established via a BPA-catalyzed three-component Michael/P-S
cascade sequence, which afforded the structurally complex and diverse target compounds in excellent
stereoselectivities (dr > 95:5; e.r. up to 98:2) [179]. N-benzylisatin 177, N-methylisatin-derived
3-indolylmethanol 178, and diethyl-2-aminomalonate 179 in CHCl3 at 45 ◦C in the presence of
(S)-[H8]-BPA-3 (with bulky 9-phenanthrenyl groups at 3,3′-positions; Scheme 33) afforded the
desired bispirooxindoles 180 with good yield (72%) and stereoselectivity (ee 82%) (Scheme 51).
1,1,2,2-tetrachloroethane (TCE) and CHCl3 were alternated as needed, while changing the molecular
sieves (MS) from 3 to 4 Å greatly improved the yield, but decreased stereoselectivity. Conversely,
lowering the temperature to 25 ◦C provided the highest stereoselectivity (ee 92%) with a relatively high
yield (61%). The incorporated THBC moiety and bispirooxindole framework are both core structures
of pharmaceutically important compounds [179].
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4.3.3. Other Pictet-Spengler Reactions in Cascade Sequences: Update (2011–2015)
P-S cyclization attends in different manners to cascade reactions, providing frameworks that are
mostly centered on THIQ or THBC motifs.
(2011) The previously cited coupling of arylethylamines 181 and arylacetaldehydes 182 to give
1-benzyl-tetrahydroisoquinoline derivatives 183 in mild reaction conditions (Scheme 52) [30].
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• Inter- and intramolecular P-S cyclizations conclude cascade sequences in the mechanism invoked
for the assembling of tetrahydro-5H-indolo[3,2-c]quinolines 186 through the formal [4 + 2]
cycloaddition of benzyl azide 184 and N-protected indole 185 (Scheme 53) [180].
• A methodology (including P-S reaction) was applied in the stereodivergent synthesis of
Corynantheine and Ipecac alkaloids and their unnatural analogues [66,181].
Molecules 2020, 25, x FOR PEER REVIEW 43 of 84 
1,1,2,2-tetrachloroethane (TCE) and CHCl3 were alternated as needed, while changing the 
molecular sieves (MS) from 3 to 4 Å  greatly improved the yield, but decreased stereoselectivity. 
Conversely, lowering the temperature to 25 °C provided the highest stereoselectivity (ee 92%) with 
a relatively high yield (61%). The incorporated THBC moiety and bispirooxindole framework are 
both core structures of pharmaceutically important compounds [179]. 
 
Scheme 51. Design and practice in the construction of THBC-fused bispirooxindoles. 
4.3.3. Other Pictet-Spengler Reactions in Cascade Sequences: Update (2011–2015) 
P-S cyclization attends in ifferent manners to cascade reactions, providing frameworks that 
are mostly centered on THIQ or THBC motifs. 
(2011) The pr viously cited coupling of arylethylamines 181 and arylacetaldehydes 182 to give 
1-benzyl-tetrahydroisoquinoline derivatives 183 in mild reaction conditions (Scheme 52) [30]. 
 
Scheme 52. One-pot synthesis of tetrahydroisoquinoline alkaloids by phosphate buffer catalysis. 
 Inter- and intramolecular P-S cyclizations conclude cascade sequences in the mechanism 
invoked for the assembling of tetrahydro-5H-indolo[3,2-c]quinolines 186 through the formal [4 
+ 2] cycloaddition of benzyl azide 184 and N-protected indole 185 (Scheme 53) [180]. 
 
Scheme 53. Two sequential P-S reactions in the cascade construction of tetrahydroindoloquinoline 
derivatives. 
 A methodology (including P-S reaction) was applied in the stereodivergent synthesis of 
Corynantheine and Ipecac alkaloids and their unnatural analogues [66,181]. 
(2012) A final intramolecular P-S cyclization was invoked for the skeletal rearrangement of 
substrate 187 to the tryptoline derivatives 188 (Scheme 54) [182]. 
Sche e 52. ne-pot synthesis of tetrahydroisoquinoline alkaloids by phosphate buffer catalysis.
Molecules 2020, 25, x FOR PEER REVIEW 43 of 84 
1,1,2,2-tetrachloroethane (TCE) and CHCl3 were alternated as needed, while changing the 
molecular sieves (MS) from 3 to 4 Å  greatly improved the yield, but decreased stereoselectivity. 
Conversely, lowering the temperature to 25 °C provided the highest stereoselectivity (ee 92%) with 
a relatively high yield (61%). The incorporated THBC moiety and bispirooxindole framework are 
both core structures of pharmaceutically important compounds [179]. 
 
Scheme 51. Design and practice in the construction of THBC-fused bispirooxindoles. 
4.3.3. Other Pictet-Spengler Reactions in Cascade Sequences: Update (2011–2015) 
P-S cyclization attends in different manners to cascade reactions, providing frameworks that 
are mostly centered on THIQ or THBC motifs. 
(2011) The p evi usly cited coupling of arylethylamines 181 and arylacetald hydes 182 to give 
1-benzyl-t trahydroisoquinoline derivatives 183 in mild reactio  conditions (Scheme 52) [30]. 
 
Scheme 52. One-pot synthesis of tetrahydroisoquinoline alkaloids by phosphate buffer catalysis. 
 Inter- and intramolecular P-S cyclizations conclude cascade sequences in the mechanism 
invoked for the assembling of tetrahydro-5H-indolo[3,2-c]quinolines 186 through the formal [4 
+ 2] cycloaddition f benzyl azid  184 and N-pr tected indole 185 (Scheme 53) [180]. 
 
Scheme 53. Two sequential P-S reactions in the cascade construction of tetrahydroindoloquinoline 
derivatives. 
 A methodology (including P-S reaction) was applied in the stereodivergent synthesis of 
Corynantheine and Ipecac alkaloids and their unnatural analogues [66,181]. 
(2012) A final intramolecular P-S cyclization was invoked for the skeletal rearrangement of 
substrate 187 to the tryptoline derivatives 188 (Scheme 54) [182]. 
Scheme 53. Two sequential P-S reactions in the cascade construction of tetrahydroindoloquinoline
derivatives.
(2012) A final intramolecular P-S cyclization was invoked for the skeletal rearrangement of
substrate 187 to the tryptoline derivatives 188 (Scheme 54) [182].Molecules 2020, 25, x FOR PEER REVIEW 44 of 84 
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erysotramidine, a dienoid-type member of Erythrina alkaloids, by a sequence (see Scheme 56) 
starting with singlet oxygen photoaddition to the furan 189a and terminating with P-S-type 
aromatic substitution to give the tetracycle 192a [184]. 
 
Scheme 56. Formal synthesis of erysotramidine from simple furan derivative. 
Hexacyclic indole alkaloids with a THBC motif were obtained by a stereoselective synthesis 
that is based on sequential P-S cyclization, N-acylation, and intramolecular Diels-Alder reactions. 
The synthetic route started with the installation of a diene motif in the THBC skeleton by a P-S 
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Sche e 54. Acid-pro oted unexpected skeletal rearrange ent.
(2013) Singlet oxygen transforms simple furan substrates in the presence of arylethylamines
into complex nitrogen-bearing aromatic poly-cycles with the structural features of important natural
products, such as Erythrina alkaloids. The combination of monosubstituted furan substrates 189
with different arylethylamines 1 in TFA/DCM at room temperature triggers a cascade reaction
sequence to generate in a novel way an N-acyliminium ion 191 precursor of tricyclic compounds 192
(Scheme 55) [183].
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Scheme 55. Conversion of a simple furan into the intact erythrinane skeleton.
The method has been used to achieve a rapid and highly effective formal synthesis of
erysotramidine, a dienoid-type member of Erythrina alkaloids, by a sequence (see Scheme 56)
starting with singlet oxygen photoaddition to the furan 189a and terminating with P-S-type aromatic
substitution to give the tetracycle 192a [184].
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Scheme 56. Formal synthesis of erysotramidine from simple furan derivative.
Hexacyclic indole alkaloids with a THBC motif were obtained by a stereoselective synthesis
that is based on sequential P-S cyclization, N-acylation, and intramolecular Diels-Alder reactions.
The synthetic route started with the installation of a diene motif in the THBC skeleton by a P-S
reaction between 5-substituted furan 2-carbaldehydes 193 (R1 = Me, Et, Br) and L-tryptophan methyl
ester. The resulting product 194ab (as a mixture of cis/trans diastereomers) that was treated with
acryloyl chlorides (DCM, Et3N at rt) afforded the α,β-unsaturated amides 195ab, which spontaneously
underwent [4 + 2] Diels–Alder cycloaddition to give the bridged indole alkaloids 196b in the exo form,
while the cis-isomer 195a remained unreacted (Scheme 57) [185].
(2014) The treatment of a novel 1,2-dinucleophile (bis-silyldienediolate 197) with
two p-methoxyphenyl (PMP) imines (198a and 198b) in a sequential Mannich/Mannich/P-S tandem
process provided complex hexahydropyrrolo[3,2-c]quinolines (Scheme 58). The α-keto ester 200,
which were obtained after a vinylogous Mannich addition (with Yb(OTf)3 in dry MeCN or DME)
and a second Brønsted acid-catalyzed Mannich reaction, spontaneously cyclizes within 10 min. into
the pyrroloquinolines 202 (as a mixture of diastereomers, optimized by screening of the solvents and
acids) (Scheme 58). Notably, being the second step triggered by the addition of the Brønsted acid,
two different imines 198a and 198b can be employed, which substantially broadens the scope of the
transformation [186].
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The reaction between N-Phth-2-formyl-L-Phe-OH (203a) and tryptamine 1a in the presence of
propylphosphonic anhydride (T3P, 1 eq.), under stirring at RT for 6h in DCM afforded the polycyclic
lactam 204 as a single trans diastereomer, in good yield (72%) and excellent diastereomeric excess
(de > 98%, Scheme 59 up). By contrast, N-Boc-2-formyl-L-Trp-OH (203b) and tryptamine 1a provided
the polycyclic spirolactam 205 instead of the expected product (Scheme 59 down). No polycyclic
lactam formation was observed from the condensation of keto acid 203b and L-Trp-OMe, whereas the
thiophene derivative (not shown) was obtained under optimized P-S conditions in 86% isolated yield
and 98% de [187].
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Scheme 59. Diastereoselective synthesis of constrained 7,5 and 7,6 fused azabicycloalkanes.
The tandem P-S/lactamization of L-phenylalanine methyl ester with methyl levulinate (206)
produced the tricyclic pyrroloisoquinoline motif 207, which was utilized as a platform containing
the pluripotent reaction site for the diversity-oriented synthesis (DOS) of a library of hybrid systems.
The structural diversity was generated through the introduction on the main motif of spiro-connected
privileged scaffolds, such as oxoindole (a), quinolone (b), cyclopent-ane/ene (c/d), and pyrrolidinone
(e) (Scheme 60) [188].
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5. The Ring-a Ring of Multi-Component Reactions
Awake–awake!
Now come and make
A ring–a ring of roses
(A.S. Stephens)
In the continuous search for an efficient synthesis of the basic skeleton of biologically active
THIQs, THBCs, or polycyclic alkaloid systems embodying them, the technique of multi-component
reaction (MCR) gained increasing attention from the chemists as an alternative to sequential multistep
synthesis [189–191]. MCR chemistry enables the rapid construction of complex and diverse structures
from readily accessible starting materials in a single operation under mild conditions. MCR is defined
as a reaction, in which three or more starting materials combine in a single event to form a single
product that contains features of all of the inputs, with the exception of condensation products, such as
H2O, HCl, or MeOH [192]. In practical terms, the order of addition of the individual components
does not matter, since multiple elements of diversity are being introduced in a single operation,
regardless of the sequence in which they are added. MCRs mostly involve a number of equilibrium
subreactions, which, like in a spiral frame culminate in the final step, an irreversible process, such as
C—C bond formation or a rearrangement [193,194]. Several descriptive tags are regularly attached to
MCRs: atom economic, the majority of the atoms of the reactants being incorporated in the products;
efficient, the final product being formed in one-step instead of multiple sequential steps; convergent,
several reactants combining in one reaction; endowed with very high bond-forming index (BFI), many
non-hydrogen atom bonds being formed in one synthetic preparation [190,195]. Multicomponent
reactions, in which all of the substrates are added at once, can also be considered to be domino
processes; alternatively, MCRs can be performed by the sequential addition of reactants, without
the isolation of intermediate species or a change of solvent. After the emergence of combinatorial
chemistry and diversity-oriented synthesis, today MCRs play a central role in the development of
modern synthetic methodology for pharmaceutical and drug discovery research [196,197].
Ugi fully recognized the huge potential of the MCR methodology, who postulated that the
reaction was ideally suited to probe structure-activity relationships via the synthesis of “collections of
compounds”, nowadays called libraries. Since its original publication in 1959 [198], the Ugi reaction
has emerged as the most well known and widely used MCR in organic synthesis. The classical Ugi
four-component reaction (U-4CR) allows for simultaneous variation of four very common starting
materials (educts): carbonyl compound (I), amine (II), isocyanide derivative (III) as a special guest and
carboxylic acid (IV). Isocyanides (formerly known as isonitriles) are the only class of stable organic
compounds with a formally bivalent carbon and a functional group fundamentally different from the
others. The most synthetically important property of isocyanides is the α-addition of nucleophiles
and electrophiles at the carbon atom. Scheme 61 shows a very simplified reaction mechanism with
carboxylic acid as the acid component. In the first step, the oxo component (I) and the amine (II)
condense to the imine 208a, via a hydroxy aminal. The Schiff base 208a upon proton activation (208b)
combines with the isocyanide (III) to give the intermediate nitrilium ion 209, which by addition of
carboxylate (IV) gives intermediate 210. Finally, the irreversible intramolecular acyl migration of 210
drives the reaction out of the ring-a-ring turning into the classic peptide-like Ugi adduct 211 [199–203].
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In earlier two-component (2C) intramolecular variations of the P-S condensation, THIQ and 
THBC scaffolds were prepared by the reaction of a solid-phase bound amine with a carbonyl 
derivative, prior to the cyclization of the incipient iminium species [204–206]. Successively, Wang 
and Ganesan added the N-acyliminium P-S reaction to the repertoire of multicomponent reactions, 
adapting a previous total synthesis of demethoxyfumitremorgin C (215a) [207] to the solid phase: 
Fmoc-protected L-tryptophan 212, which was immobilized on polystyrene-Wang resin, was treated 
with senecialdehyde (R = ‒CH = CMe2) and trimethyl orthoformate to give the imine 213a. The 
addition of Fmoc-L-proline chloride gave rise to N-acyliminium P-S cyclization to 214, which, in 
turn, treated with piperidine undergoes deprotection, diketopiperazine ring closure, and 
concomitant resin cleavage. The natural product 215a was obtained, together with its trans epimer 
(Scheme 62). Analogous compounds 215 were also prepared varying the aldehyde and/or replacing 
the proline unit by other amino acids [208]. On the other hand, Bonnet and Ganesan obtained THBC 
hydantoins (Scheme 62) with a similar cis/trans ratio by a slightly modified strategy [110]. Finally, 
van Loeveijin et al. reported a similar approach for the construction of a 42-membered library of 
fumitremorgin-type indolyl-diketopiperazines (215), such as verruculogen (Scheme 62) [209]. 
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5.1. Ugi Meets Pictet-Spengler
In earlier two-component (2C) intramolecular variations of the P-S condensation, THIQ and THBC
scaffolds were prepared by the reaction of a solid-phase bound amine with a carbonyl derivative, prior
to the cyc ization of the incipient iminium species [204–206]. Succes ively, Wang and Ganesan added
the N-acyliminium P-S reaction to the repertoire of multicomponent reactions, adapting a previous total
synthesis of demethoxyfumitremorgin C (215a) [207] to the solid phase: Fmoc-protected L-tryptophan
212, which was immobilized on polystyrene-Wang resin, was treated with senecialdehyde (R = —CH
= CMe2) and trimethyl orthoformate to give the imine 213a. The addition of Fmoc-L-proline chloride
gave rise to N-acyliminium P-S cyclization to 214, which, in turn, treated with piperidine undergoes
deprotection, diketopiperazine ring closure, and concomitant resin cleavage. The natural product
215a was obtained, together with its trans epimer (Scheme 62). Analogous compounds 215 were
also prepared varying the aldehyde and/or replacing the proline unit by other amino acids [208].
On the other hand, Bonnet and Ganesan obtained THBC hydantoins (Scheme 62) with a similar cis/trans
ratio by a slightly modified strategy [110]. Fin lly, van Loeveijin et al. reported a similar approach
for the co struction of 42-membered library of fumitr morgin-type indolyl-diketopiperazines (215),
such as verruculogen (Scheme 62) [209].
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The P-S-adducts finally appeared at the edge of the ring-a-ring in the framework of a 
substantial body of work devoted to post condensation modifications of Ugi-4CR educts 211. 
Dömling and Ugi first reported the combination of Ugi and P-S reactions and included the amino 
acid tryptophan, phthalic aldehyde 216, and t-butyl isocyanide 217 as substrates of the synthesis of 
complex polycyclic products containing the THIQ and THBC motifs. The non-isolable Ugi product 
afforded the pentacyclic compound 218 after spontaneous P-S cyclization and the following 
oxidation, while other aromatic amino acids, such as phenylalanine (R = H), tyrosine (R = 4-OH), 
and DOPA (R = 3,4-di-OH), produced tricyclic compounds, such as 219 (Scheme 63) [199]. 
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Scheme 62. Indolyl diketopiperazines (215a–d) and THBC hydantoins synthesized by solid phase
multicomponent (MCR)/P-S approach.
The P-S-adducts finally appeared at the edge of the ring-a-ring in the framework of a substantial
body of work devoted to post condensation modifications of Ugi-4CR educts 211. Dömling and Ugi
first reported the combination of Ugi and P-S reactions and included the amino acid tryptophan,
phthalic aldehyde 216, and t-butyl isocyanide 217 as substrates of the synthesis of complex polycyclic
products containing the THIQ and THBC motifs. The non-isolable Ugi product afforded the pentacyclic
compound 218 after spontaneous P-S cyclization and the following oxidation, while other aromatic
amino acids, such as phenylalanine (R = H), tyrosine (R = 4-OH), and DOPA (R = 3,4-di-OH), produced
tricyclic compounds, such as 219 (Scheme 63) [199].
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The Ugi-4CR/P-S-2CR became quite popular for the rapid assembly of diverse polycyclic scaffolds.
El Kaim et al. reported a classic version (A) of Ugi-4CR/P-S sequence (Scheme 64, up) [210] with the
use of phenethyl isocyanide 220 for the obtainment of diketopiperazines 221, while Dömling et al.
introduced tryptophan-derived isocyanides 224 in a version (B) of Ugi/P-S reactions for the preparation
of polycyclic indole alkaloid scaffolds 225 (Scheme 64, down) [211].
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of tandem MAO desymmetrization/MCR/P-S cyclization for the asymmetric synthesis of alkaloid-
like polycyclic compounds [213,214], as well as for the synthesis of cyanocycline A and 
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compounds of this large group of reactions are reflected in the numerous preclinical and 
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5.2. Update of Ugi/Pictet-Spengler Combinations 
(2011) Dömling and coworkers elaborated on their previous Ugi-3CR/P-S reaction sequence 
(Scheme 65 [212]), the synthesis of a small focused library of polycyclic ring systems, based on 
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Scheme 64. Classic version A (up) and versatile version B (down) of Ugi-4CR/P-S sequence.
Dömling and coworkers reported an efficient and flexible 2-step procedure for the synthesis
of complex multicyclic indole alkaloid-type compounds 227, which feature Ugi MCR and P-S
reactions (Scheme 65). The final product is a highly complex molecule that contains six cycles
in total, four heterocycles (pyrrole, piperazinone, hydropyridine, γ-lactam) and two carbocycles
(benzene, cyclopentane) [212].
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Scheme 65. Ugi-4CR/P-S-2CR sequence for hexacyclic architecture.
Other notable employments of Ugi/P-S sequence prior to 2011 can be found in the combination of
tandem MAO desymmetrization/MCR/P-S cyclization for the asymmetric synthesis of alkaloid-like
polycyclic compounds [213,214], as well as for the synthesis of cyanocycline A and bioxalomycin
β2 [215]. The mature state and the use in the synthesis of biologically active compounds of this large
group of reactions are reflected in the numerous preclinical and development drugs, for instance,
almorexant (first-in-class orexin I antagonist) and retosiban (oxytocin receptor antagonist) [216,217].
5.2. Update of Ugi/Pictet-Spengler Combinations
(2011) Dömling and coworkers elaborated on their previous Ugi-3CR/P-S reaction sequence
(Scheme 65 [212]), the synthesis of a small focused library of polycyclic ring systems, based on
phenylethylamine-derived isocyanides 224. All the suitable bifunctional oxocarboxylic acids 228
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reacted satisfactorily with aminoaldehyde dimethyl acetal and the aryl ethyl isocyanides 224 to afford
Ugi-adducts 229 with yields that range from 38 to 62% (Scheme 66). P-S reaction of intermediates 229
afforded polycyclic scaffolds 230, in the presence of formic acid at RT for the more reactive 229c and
with methanesulfonic acid at 70 ◦C for the less reactive 229a and 229b, which also required longer
reaction times [218].
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Scheme 66. Ugi-3CR/P-S ring-closure reaction sequence for the synthesis of tetra- and
pentacyclic structures.
A sequential Ugi/P-S/reductive methylation reaction was used for the synthesis of the
piperazinohydroisoquinoline ring system, starting from aminoacetaldehyde dimethyl acetal,
(−)-(S)-N-Boc-3-(3,4-dimethoxyphenyl) alanine 231, and t-butyl isocyanide 217, in combination with
several aldehydes 30 (Scheme 67). The Ugi-4CR/P-S-2CR reaction was completed in a straightforward
manner within 1–2 h when the reaction was carried out at 50 ◦C while using microwave irradiation.
The one-pot transformation of the Ugi-adducts 232 into the desired piperazinohydrosoquinolines 234
via iminium intermediates 233 was performed with comparable yields, simply by evaporating the
solvent from the reaction flask after the completion of the Ugi reaction and then adding the reactive
mixture CH2O/HCOOH [219].
olecules 2020, 25, x FOR PEER REVIE  51 of 84 
inter ediates 229 afforde  polycyclic scaffolds 230, in the presence of for ic acid at RT for the 
ore r active 229c and ith ethanesulfonic acid at 70 °  for the less reactive 229a and 229b, 
hich also required longer reaction ti es [218]. 
 
Sche e . gi-3CR/P-S ring-closure reaction sequence for the synthesis of tetra- and pentacyclic 
structures. 
 sequential gi/P-S/reductive ethylation reaction as used for the synthesis of the 
piperazinohydroisoquinoline ring syste , starting fro  a inoacetaldehyde di ethyl acetal, (−)-(S)-
-Boc-3-(3,4-di ethoxyphenyl) alanine 231, and t-butyl isocyanide 217, in co bination ith 
several aldehydes 30 (Sche e 67). The gi-4 R/P-S-2 R reaction as co pleted in a 
straightfor ard anner ithin 1–2 h hen the reaction as carried out at 50 °  hile using 
icro ave irradiation. The one-pot transfor ation of the gi-adducts 232 into the desired 
piperazinohydrosoquinolines 234 via i iniu  inter ediates 233 as perfor ed ith co parable 
yields, si ply by evaporating the solvent fro  the reaction flask after the co pletion of the gi 
reaction and then adding the reactive ixture 2 /  [219]. 
 
Sche e 67. Synthesis of the piperazinohydroisoquinoline syste  hile using a sequential gi/P-
S/reductive ethylation reaction protocol. 
The Les a group carried out the synthesis of a novel Phe- la dipeptido i etic 235 (Figure 4), 
built up on a diazaspiro-cyclic lacta  core. olecular odeling, IR, R, and X-ray diffraction 
experi ents agree on the presence of a strong intra olecular hydrogen bond supporting the ability 
of this spiro co pound to act as type II′ β-turn inducer [220]. 
Scheme Synthesis of the piperazinohydroisoqu oline system while using a sequential
Ugi/P-S/reductive methylation reacti n protocol.
Molecules 2020, 25, 414 49 of 82
The Lesma group carried out the synthesis of a novel Phe-Ala dipeptidomimetic 235 (Figure 4),
built up on a diazaspiro-cyclic lactam core. Molecular modeling, IR, NMR, and X-ray diffraction
experiments agree on the presence of a strong intramolecular hydrogen bond supporting the ability of
this spiro compound to act as type II′ β-turn inducer [220].
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Figure 4. Ugi/P-S-based synthetic β-turn and γ-turn peptidomimetics.
(2012) In the framework of a program focused on the identification of new peptidomimetic of
potential interest in drug discovery, Lesma and coworkers reported a two-step efficient route for the
synthesis of THBC-based compounds as privileged molecular targets in the design of potential reverse
turn mimics [221]. The authors applied the Ugi/P-S sequence for a rapid assembly of peptidomimetic
scaffolds of type 236. NMR and molecular modeling on the corresponding methyl carboxamide
N-acetyl derivatives both confirmed a β-turn like conformation for the cis-isomer 236a and γ-turn for
the trans-isomers 236b-c (Figure 4) [222].
Praziquantel (PZQ) is the only effective drug for the treatment of schistosomiasis, a high volume
neglected tropical disease that affects more than 200 million people worldwide. Liu et al. developed
a convergent and versatile synthetic method to prepare easily accessible and highly diversified PZQ
derivatives for extensive structure-activity relationship studies. The approach includes Ugi-4CR,
followed by a P-S ring closure in a sequential one-pot, two-step procedure (Scheme 68). Even though
the products were found to be slightly less active than the mother drug PZQ, the Ugi/P-S reaction
sequence remains the shortest and scalable approach towards a future bioactivity-guided optimization
of PZQ analogous [223].
A novel stereoselective Ugi-type reaction of the four highly variable starting materialsα-amino acid
(e.g., leucine), oxo component I (e.g., 2-fluorobenzaldehyde), isocyanide 224 (e.g., benzyl isocyanide),
and primary or secondary amine (e.g., morpholine), thus comprising a novel and true 4-CR, provided the
iminodicarboxamide 239 (Scheme 69). The extensive optimization of the reaction included: the solvent,
a mixture MeOH/H2O = 4:1, as a compromise in solubility for the different classes of starting materials;
the temperature, RT instead of microwave conditions avoided the formation of undesired side products);
the reaction time, three days, and the catalyst. The scope of the reaction was investigated while using
representative starting material of each class. The use of bifunctional starting materials allowed for
cyclizing the initially formed Ugi products, such as compound 240a, whih was obtained by P-S reaction
and deprotective cyclization [224].
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(2013) The authors presented a paper containing full experimental detail on the synthesis of 
indole (240) and THIQ (242) derivatives that were obtained using conc. HCOOH at room 
temperature by the P-S reaction reported in the previous paper [224]. Notably, the cyclization was 
performed without purification of the initial Ugi product. The structure of the indolo annulated 
derivative 240b (R1 = CH2CH2OCHO; R2 = R3 = Me) was confirmed by single-crystal X-ray analysis. 
Structures 240 and 242 can be found in the architectures of potential natural-product targets, such 
as the antitumor quinocarcin or the insecticidal notoamide B (Scheme 70) [225]. 
(2013) The Ugi reaction of four suitably components and post-condensation reactions can 
provide four heterocyclic scaffolds: tetrahydroimidazo[1,2-a]pyrazine-2,6(3H,5H)dione, 
pyrrolidinedione, and isoindolone systems have been yielded via post-Ugi secondary cyclization, 
while the unique structures of the strained tricyclic 3,9-diazabicyclo[3.3.1.]nonane skeletons 240/242 
were obtained by a P-S reaction, where the required functional groups, an electron rich aromatic 
ring and the oxo partner, were conveniently introduced via the α-amino acid and the primary 
amine component, respectively. Several analogous reactions show the potential of this 
transformation (not shown) [226]. 
Scheme 69. Assembly of iminodicarboxa ides by a truly gi-4 R follo ed by P-S cyclization.
(2013) The authors presented a paper containing full experimental detail on the synthesis of
indole (240) and THIQ (242) derivatives that were obtained using conc. HCOOH at room temperature
by the P-S reaction reported in the previous paper [224]. Notably, the cyclization was performed
without purification of the initial Ugi product. The structure of the indolo annulated derivative 240b
(R1 = CH2CH2OCHO; R2 = R3 = Me) was confirmed by single-crystal X-ray analysis. Structures 240
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and 242 can be found in the architectures of potential natural-product targets, such as the antitumor
quinocarcin or the insecticidal notoamide B (Scheme 70) [225].Molecules 2020, 25, x FOR PEER REVIEW 54 of 84 
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(2015) The authors designed novel bi- and tri-cyclic scaffolds based on the Ugi tetrazole synthesis.
The reaction of propionaldehyde (243), 3,4-dimethoxyphenethylamine (181), isocyanoacetaldehyde
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dimethyl acetal (244), and trimethylsilyl azide (245) in MeOH at room temperature afforded after
18 h the classical Ugi product 246, which in turn gave the P-S cyclized product 247 (67% yield) by
simple treatment with methanesulfonic acid for 18 h at room temperature (Scheme 71). The scope of
the methodology was examined with different oxo components and various aryl ethyl amines that
produce a large range of results. Diastereomeric mixtures were obtained, but a major stereoisomer was
isolated in some cases [227].
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6.1.1. Biogenetic Studies
Strictosidine synthase (STR) and norcoclaurine synthase (NCS) are the best known and studied
enzymes among the Pictet-Spenglerases. By the enzymatic P-S condensation of tryptamine 1a and an
iridoid monoterpene, namely the secologanin, strictosidine synthase (EC 4.3:3:2) triggers the formation
of strictosidine, the common precursor of the biosynthesis of more than 2500 monoterpene indole
alkaloids of the Apocynaceae family (Scheme 72 up) [228,231–235]. STR enzyme, which was characterized
in many plants, such as Rauwolfia serpentina, Catharantus roseus, and Ophiorrhiza plumila, only produces
the 1α(S)-epimer (strictosidine), but not the 1β(R)-epimer (vincoside). However, strictosidine synthase
was demonstrated to serve as precursor for tetrahydroisoquinolines (THIQs), not only with α- but also
with β-configuration at C-1 chiral center [236,237].
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Conversely, the enzy e norcoclaurine synthase (NCS; EC 4.2.1.78), which is isolated from
Thalictrum flavum (Tf NCS), is responsible of the synthesis of benzylisoquinoline alkaloids (BIAs),
which include morphine and codeine, through the precursor (S)-norcoclaurine (formed by the P-S
condensation of dopamine and 4-hydroxyphenylacetaldehyde (4-HPAA) (Scheme 72 down) [238,239].
For instance, the anticancer candidate noscapine was obtained via this pathway [240].
An enzyme mechanism for natural substrates was developed on the basis of the holoTfCNS crystal
structure, featuring dopa ine and a non-productive aldehyde. This “HPAA-first” mechanism suggests
the binding of 4-hydroxyphenylacetylaldehyde (4-HPAA) to the enzyme prior to dopamine [241,242].
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Deacetylipecoside synthase (DIS) is the enzyme that catalyzes the Pictet-Spengler-like condensation
of dopamine and secologanin to form two epimers, 1α-N-deacetylisoipecoside, the precursor
of alkaloids, emetine, and cephaeline, and 1β-N-deacetylipecoside, which is converted to
tetrahydroisoquinoline monoterpene glucosides, such as ipecoside (Scheme 73). Emetine, ipecoside,
and similar natural products are named collectively Ipecac alkaloids, having been isolated from
Psychotria ipecacuanha. Their biosynthesis has been extensively studied [243–245], but no new paper
appeared in the 2011–2015.
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6.1.2. Biosynthesis: Update 2011–2015
(2012) Oikawa and coworkers demonstrated that the core scaffold of microbial THIQ antitumor
antibiotic of the type bis-THIQ, such as saframycin A and ecteinascidin, is biosynthesized by
a nonribosomal peptide synthetase (NRPS), which catalyzes a highly unusual seven step transformation
while using a simple fatty acyl-dipeptidyl coenzyme A (248a) and a modified tyrosine analogue (249a).
The authors proposed a biosynthetic pathway that involves multiple reductions (Red) of thioester
intermediates (250a and 252a) and two rounds of P-S cyclization (Scheme 74) [246,247]. The group
described a protocol for the biochemical characterization of saframycin NRPS SfmC and showed
that the P-S reaction relies heavily on the chain length of the cryptic long acyl chain in the peptide
substrates [248].
(2013) The Oikawa group reported then the identification of the biosynthetic gene clusters
of quinocarcin and the antitumor antibiotic SF-1739, which share a common type II tetracyclic
tetrahydroisoquinoline (THIQ)-pyrrolidine core scaffold. The authors proposed a reaction pathway for
the construction of the quinocarcin core scaffold (sketched in Scheme 75), with similar protagonists as
for saframycin and involving one P-S and one intramolecular Mannich reaction [249].
Ju and coworkers identified three genes mcbA, mcbB, and mcbC as the solely
responsible for scaffold construction of marinacarbolines (MCBs), 1-acetyl-β-carboline (255a),
and 1-acetyl-3-carboxy-β-carboline (255b), which were isolated from Marinactispora thermotolerans.
In particular, mcbB was proposed to be a multifunctional enzyme that catalyzes the P-S reaction of
tryptophan and oxaloacetaldehyde for the assembly of the tetrahydro-β-carboline (THBC) 254 skeleton,
followed by decarboxylation and C-ring oxidation to β-carbolines (Scheme 76) [250].
Abe et al. confirmed that mcbB indeed catalyzes the PS condensation as well as the decarboxylation
and oxidation reactions by crystallographic studies and biochemical characterization. The resolution
of the crystal structure of mcbB complexed with tryptophan revealed a totally different structure
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from those of other P-S cyclization catalyzing enzymes from plants, such as strictosidine synthase or
norcoclaurine synthase [251].
(2014) The crystal structure of mcbB was also analyzed and its catalytic mechanism discussed by
another group [252].Molecules 2020, 25, x FOR PEER REVIEW 58 of 84 
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6.1.3. Biocatalysis
Biotechnological approaches are gaining importance for the production of alkaloids that cannot
be isolated from their natural sources in quantities that were comparable with the demand of
modern medicine.
Recent advances in metabolic engineering have enabled the tailored production of plant secondary
metabolites in microorganisms. A Japanese group, using selected enzyme to construct a tailor-made
biosynthetic pathway, being produced the plant benzylisoquinoline alkaloid, (S)-reticuline (vide infra:
Scheme 76) with a yield of 46.0 mg/L culture medium (Escherichia coli fermentation system) [253].
Analogously, O’Connor and coworkers suppressed tryptamine biosynthesis in Catharanthus roseus
hairy root cultures, introduced an unnatural tryptamine analog to the silenced plant cells, and obtained
a variety of novel products [254,255].
Enzymatic catalysis has been proven to be useful for a number of synthetic
biotransformations [256,257], although natural product biosynthetic enzymes often have narrow
substrate scope that limits their use as biocatalysts. Pictet-Spenglerases are expected to produce
nitrogen heterocycles with excellent stereochemical control of the resulting chiral center. For instance,
strictosidine synthase from Ophiorrhiza pumila can utilize a range of simple achiral aldehydes and
substituted tryptamines to form highly enantioenriched (ee > 98%) THBCs via the P-S reaction.
These findings represent the first example of aldehyde substrate promiscuity in the strictosidine
synthase family of enzymes [258].
A recombinant norcoclaurine synthase (NCS) from E. coli was used to prepare (S)-norcoclaurine
(R = H), starting from tyrosine and dopamine (R = H) as substrates in a one-pot, two-step process.
Tyrosine was first chemically decarboxylated by stoichiometric amount of NaClO to generate the
aldehyde species (4-HPAA), to which the enzyme and tyrosine were added (Scheme 77). The optimized
process afforded (S)-norcoclaurine (R = H; ee 93%) in 81% yield and allowed for the recycling of the
enzyme [259].
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Successively, the same group achieved the fully enzymatic asymmetric synthesis of substituted
tetrahydroisoquinolines analogs of norcoclaurine in two steps, starting from dopamine and a set of
amine substrates by an oxidation performed with a diamine oxidase from plant Lathyrus cicero L.,
followed by the P-S reaction being catalyzed by the recombinant NCS from Thalictrum flavum. In the
first step, various aliphatic and aromatic amines were transformed into the corresponding aldehydes
by the broad specificity of diamine oxidase enzyme, while the second step afforded chiral substituted
THIQs in good yield [260].
6.1.4. Biotransformations: Update 2011–2015
(2011) Pictet-Spenglerases (P-Sases) are highlighted among the enzymes that have been employed
for C-C bond forming reaction on a preparative scale [261]. In concert with Oikawa model for
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saframycin [246], the presumed activity of a P-Sase was invoked in the biosynthetic pathway for
anticancer agent ET-743 [262].
(2012) O’Connor and coworkers described the substrate scope and limitations of a NCS from
Thalictrum flavum (Tf NCS). Nineteen aldehyde analogs 256a–n, which were synthesized or commercially
available, were treated (at 1 mM concentration) with dopamine and Tf NCS (300 µM) in TRIS buffer
(100 µM, pH 7) to give the corresponding norcoclaurine derivatives 257 in enantioselective fashion
(S-form) (Scheme 78) [263]. Including for each reaction inactive (boiled) enzyme controlled the
enzymatic background. As a result, Tf NCS proved to have exceptionally broad aldehyde substrate
specificity, turning over aldehydes 256a–n. Only the THIQs corresponding to (the small) formaldehyde
(HCHO) and acetaldehyde (CH3CHO), as well as benzaldehyde (C6H5CHO), could not be detected.
By contrast, NCS showed a strict requirement for the amine substrate, which is dopamine. In fact,
neither tryptamine, which is the natural substrate of the enzyme in the plant, nor commercially
available 3,4-disubstituted phenylethylamines (not shown), provided any product with native 4-HPAA.
This substrate specificity is consistent with earlier studies [238,239] that require the amine substrate to
contain a hydroxy group at the C-3 position of the aromatic ring. In conclusion, these findings revealed
that NCS could be used as a catalyst to yield a variety of substituted THIQs.
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coli. L-tyrosine (obtained from glycerol via a tyrosine over-producing pathway) is oxidized by 
tyrosinase to L-DOPA, which in turn is transformed into dopamine by DOPA decarboxylase 
(DODC). Finally MAO oxidizes dopamine to 3,4-DHPAA and these last two compounds are 
spontaneously converted to (R,S)-THP through a non-enzymatic P-S reaction (Scheme 80) [266]. In 
the synthetic pathway from glycerol to tyrosine to 3,4-DHPAA, previously reported [254], NCS was 
used instead for THP synthesis. 
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with potentially new biological activities [265].
(2014) Nakagawa et al. developed a production system of (R,S)-tetrahydropapaveroline (THP)
by altering the reticuline synthetic pathway [253] that was previously constructed while using E. coli.
L-tyrosine (obtained from glycerol via a tyrosine over-producing pathway) is oxidized by tyrosinase
to L-DOPA, which in turn is transformed into dopamine by DOPA decarboxylase (DODC). Finally
MAO oxidizes dopamine to 3,4-DHPAA and these last two compounds are spontaneously converted
to (R,S)-THP through a non-enzymatic P-S reaction (Scheme 80) [266]. In the synthetic pathway from
glycerol to tyrosine to 3,4-DHPAA, previously reported [254], NCS was used instead for THP synthesis.
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The authors observed novel kinetic parameters that show NCS to operate with low catalytic efficiency.
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aldehyde binding site, resulted in a modification of the aldehyde activity profile, strongly supporting
the mechanism in question [270].
6.2. Chemistry and biology of Pictet-Spengler Reaction
Started in the old world of natural products, the P-S reaction pathway culminates in the modern
technological applications of enzymes.
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Aldehyde- and ketone-functionalized proteins are appealing substrates for the development of
chemically modified biotherapeutics and protein-based materials.
The close tie of P-S reaction with biology materializes in the iso-Pictet-Spengler reaction as the
basis of a bond that connects the orthogonal bioconjugation of a small molecule with a large protein.
6.2.1. Iso-Pictet-Spengler
Natural and synthetic compounds containing the THBC framework are endowed with
an extraordinary range of biological activity [271]. The closely related tetrahydro-γ-carboline (THGC)
scaffold is unknown among natural product structures, however, holds considerable potential as
a template for drug discovery [272,273].
Klausen and Jacobsen reported that chiral thiourea derivatives in combination with benzoic acid
promote catalytic asymmetric iso-P-S reactions of electronically and sterically diverse imines, providing
unprotected THBCs in high ee and yield [274].
(2011) Through an approach founded on the above findings, Jacobsen and coworkers described
a straightforward and direct route to enantiomerically enriched THGCs 261 via the one-pot
condensation/cyclization of 2-substituted-indolyl-ethylamines (isotryptamines) 260 and aldehydes or
ketones I (Scheme 81). In a reaction defined “iso-Pictet-Spengler”, chiral thioureas TH-2, TH-3, or TH-4
(20 mol%) (see Scheme 81) and benzoic acid PhCO2H (10–20 mol%) were found as the more effective
cocatalysts and gave the THGC 261a (X = H, R = i-Pr; R′ = H) with a 97% yield and 95% ee. [275]. Ketone
substrates I were also successfully applied to the iso-P-S protocol. The authors explored also whether
the THGC framework might undergo analogous transformations into structurally and stereochemically
complex alkaloid scaffolds. They targeted the synthesis of the spirocyclic oxindole 261b (X = H; R =
Me; R′ = 4-ClC6H4) [276].
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1-aryl-N-tosyl-2,3,4,5-tetrapyrido[4,3b]indole 216 (Scheme 83) [275].
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6.2.2. Orthogonal Bioconjugation 
The bioorthogonal chemical reactions are the key for selective modifications of biological 
species and they involve the creation of non-biological molecules that exert an effect on or reveal 
new information about biological systems. The bioorthogonal ligation between a biomolecule and a 
reactive partner does not perturb other chemical functionality naturally found within the cell 
system [279]. Recently, McKay and Finn provided an update on the last developments in the 
selective chemical modification of biological molecules, the so-called bioorthogonal chemistry, and 
analyzed strategies and applications [280]. Aldehydes and ketones were among the functionalities 
amenable to incorporation into biomolecules for their synthetic accessibility and small size. Several 
chemical, enzymatic, and genetic methods have been developed to introduce aldehydes and 
ketones into protein sites specifically [279]. Historically, oximes and hydrazones have been used for 
ligation to carbonyls, which, as mild electrophiles are typically conjugated with α-effect 
nucleophiles, such as substituted hydrazines or alkoxyamines. However, the resulting C = N 
linkages are susceptible to hydrolysis under physiologically relevant conditions [279,280]. 
Moreover, oxime formation requires acidic conditions (pH 4.5) to proceed at any appreciable rate, 
while prolonged exposure to acid might damage sensitive biomolecules. A C-C bond was taken in 
consideration and the classic P-S cyclization was applied to the N-terminal labeling of horse heart 
myoglobin to overcome the instability of the oxime constructs [281–283], but to avoid harsh acidic 
conditions, which were not consistent with protein bioconjugation, the used the incubation of the 
protein and tryptophan or tryptamine in phosphate buffer (pH 6.5) at 37 °C for 18 h as reaction 
conditions. 
(2013) Bertozzi and coworkers introduced a P-S ligation to prepare hydrolytically stable 
conjugates with glyoxyl- and formylglycine-modified proteins, including a monoclonal antibody 
[281]. The canonical aliphatic amine was replaced with alkoxyamine since kinetic studies of the 
classic P-S reaction suggested the formation of the iminium ion as the rate-limiting step. In addition, 
the functionality was moved to the 2-position, leaving the more nucleophilic 3-position to engage in 
2-linked o-a inobenzylindoles 217 give ith trifluoro ethylketones, in the presence of chiral
spirocyclic phosphoric acids (SPA-2, see Scheme 33), optically active benzazepinoindoles 218, bearing
trifluoromethylated quaternary stereocenters (Scheme 84) [278].
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6.2.2. Orthogonal Bioconjugation
The bioorthogonal chemical reactions are the key for selective modifications of biological species
and they involve the creation of non-biological molecules that exert an effect on or reveal new
information about biological systems. The bioorthogonal ligation between a biomolecule and
a reactive partner does not perturb other chemical functionality naturally found within the cell
system [279]. Recently, McKay and Finn provided an update on the last developments in the selective
chemical modification of biological molecules, the so-called bioorthogonal chemistry, and analyzed
strategies and applications [280]. Aldehydes and ketones were among the functionalities amenable
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to incorporation into biomolecules for their synthetic accessibility and small size. Several chemical,
enzymatic, and genetic methods have been developed to introduce aldehydes and ketones into
protein sites specifically [279]. Historically, oximes and hydrazones have been used for ligation to
carbonyls, which, as mild electrophiles are typically conjugated with α-effect nucleophiles, such as
substituted hydrazines or alkoxyamines. However, the resulting C = N linkages are susceptible to
hydrolysis under physiologically relevant conditions [279,280]. Moreover, oxime formation requires
acidic conditions (pH 4.5) to proceed at any appreciable rate, while prolonged exposure to acid might
damage sensitive biomolecules. A C-C bond was taken in consideration and the classic P-S cyclization
was applied to the N-terminal labeling of horse heart myoglobin to overcome the instability of the oxime
constructs [281–283], but to avoid harsh acidic conditions, which were not consistent with protein
bioconjugation, the used the incubation of the protein and tryptophan or tryptamine in phosphate
buffer (pH 6.5) at 37 ◦C for 18 h as reaction conditions.
(2013) Bertozzi and coworkers introduced a P-S ligation to prepare hydrolytically stable
conjugates with glyoxyl- and formylglycine-modified proteins, including a monoclonal antibody [281].
The canonical aliphatic amine was replaced with alkoxyamine since kinetic studies of the classic
P-S reaction suggested the formation of the iminium ion as the rate-limiting step. In addition, the
functionality was moved to the 2-position, leaving the more nucleophilic 3-position to engage in the
electrophilic substitution, such as in an “iso-Pictet-Spengler” reaction [276]. Finally, the aminooxy
substituent was methylated to provide a more reactive oxyminium ion intermediate [281–283].
Compound 272a (R′ = CH2CH2CO2H) was prepared in few steps, starting from indole-2-methanol,
and culminating in the rapid formation under acidic conditions of dihydroxy-β-oxa-γ-carboline 273a,
a product that was hydrolytically more stable than the model oxime (Scheme 85). Compounds 273b
and 273c were prepared to evaluate the iso-P-S ligation as a means to label aldehyde-functionalized
proteins. The first one was obtained by treatment of Teoc protected 272a with amino-poly (ethylene
glycol)- functionalized biotin, followed by deprotection with CsF, to give 272b, and by ligation to
the N-terminal glyoxyl moiety of horse heart myoglobin (glyoxyl Mb). Analogously, the indole 272c
was synthesized by a similar sequence of coupling 272a with Alexa Fluor 488 (AF488), while the
oxacarboline 273c was obtained by ligation with the formylglicine-functionalized C-terminus of the
six-residue peptide sequence LCTPSR of maltose-binding protein (FGly-MBP). The studies put in
evidence that P-S ligation might enhance the metabolic, enzymatic, and chemical functionalization of
proteins and other biomolecules.
Molecules 2020, 25, x FOR PEER REVIEW 66 of 84 
the electrophilic substitution, such as in an “iso-Pictet-Spengler” reaction [276]. Finally, the 
aminooxy substituent was methylated to provide a more reactive oxyminium ion intermediate 
[281–283]. Compound 272a (R′ = CH2CH2CO2H) was prepared in few steps, starting from indole-2-
methanol, and culminating in the rapid formation under acidic conditions of dihydroxy-β-oxa-γ-
carboline 273a, a product that was hydrolytically more stable than the model oxime (Scheme 85). 
Compounds 273b and 273c were prepared to evaluate the iso-P-S ligation as a means to label 
aldehyde-functionalized proteins. The first one was obtained by treatment of Teoc protected 272a 
with amino-poly (ethylene glycol)- functionalized biotin, followed by deprotection with CsF, to 
give 272b, and by ligation to the N-terminal glyoxyl moiety of horse heart myoglobin (glyoxyl Mb). 
Analogously, the indole 272c was synthesized by a similar sequence of coupling 272a with Alexa 
Fluor 488 (AF488), while the oxacarboline 273c was obtained by ligation with the formylglicine-
functionalized C-terminus of the six-residue peptide sequence LCTPSR of maltose-binding protein 
(FGly-MBP). The studies put in evidence that P-S ligation might enhance the metabolic, enzymatic, 
and chemical functionalization of proteins and other biomolecules. 
 
Scheme 85. Synthesis of hydrolytically stable conjugates with glyoxyl- and formylglycine-modified 
proteins through a reactive oxyminium ion intermediate. 
(2013) Rabuka and coworkers introduced a new reaction, the hydrazino-Pictet-Spengler (HIPS) 
ligation, which proceeds quickly around neutral pH and allows for one-step labeling of aldehyde-
functionalized proteins under mild conditions. The HIPS ligation product is very stable (>5 days) in 
human plasma when compared to an oxime –linked conjugate (~1 day) [283]. 
(2014) Hydrazino-iso-Pictet-Spengler (HIPS) chemistry was successfully employed to prepare 
antibody-drug-conjugates (ADCs) [284,285]. 
(2015) The site-specific HIPS ligation was also used for labeling covalently proteins with a 
fluorophore [286]. 
A paper from Kudirka and Rabuka reviews the advance in site-specific ADCs for cancer 
therapy and highlights the chemistry of the reaction, dubbed iso-Pictet-Spengler ligation [287]. 
6.2.3. Unnatural Compounds from Fungal Pictet-Spengler Biosynthesis 
The P-S reaction contributes greatly to framework diversification of important alkaloids by 
forming a piperidine ring condensed to aromatic ring or indole moiety with plant-derived Pictet-
Spenglerases. Piperidine ring-containing secondary metabolites have also been found in bacteria 
(e.g., THIQs 274 from Streptomyces lavendulae [288] and THBCs 275 from Marinactinospora 
thermotolerans [250]), in sponges (e.g., marine natural product hyrtioreticulin F from the sponge 
Hirtios reticulatis [289]) and animals (e.g., THBC derivatives 276 from rat brain [290]) (resumed in 
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(2013) Rabuka and coworkers introduced a new reaction, the hydrazino-Pictet-Spengler
(HIPS) ligation, which proceeds quickly around neutral pH and allows for one-step labeling of
aldehyde-functionalized proteins under mild conditions. The HIPS ligation product is very stable
(>5 days) in human plasma when compared to an oxime –linked conjugate (~1 day) [283].
(2014) Hydrazino-iso-Pictet-Spengler (HIPS) chemistry was successfully employed to prepare
antibody-drug-conjugates (ADCs) [284,285].
(2015) The site-specific HIPS ligation was also used for labeling covalently proteins with
a fluorophore [286].
A paper from Kudirka and Rabuka reviews the advance in site-specific ADCs for cancer therapy
and highlights the chemistry of the reaction, dubbed iso-Pictet-Spengler ligation [287].
6.2.3. Unnatural Compounds from Fungal Pictet-Spengler Biosynthesis
The P-S reaction contributes greatly to framework diversification of important alkaloids by forming
a piperidine ring condensed to aromatic ring or indole moiety with plant-derived Pictet-Spenglerases.
Piperidine ring-containing secondary metabolites have also been found in bacteria (e.g., THIQs 274 from
Streptomyces lavendulae [288] and THBCs 275 from Marinactinospora thermotolerans [250]), in sponges
(e.g., marine natural product hyrtioreticulin F from the sponge Hirtios reticulatis [289]) and animals
(e.g., THBC derivatives 276 from rat brain [290]) (resumed in Figure 5) and a Pictet-Spenglerase has
been presumed to be involved in their biosynthetic pathways.
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moiety in pathways of fungal alkaloids are based on building blocks, such as L-tryptophan and the 
related 4-dimethylallyl-tryptophan (4-DMAT, by prenylation) and trypamine (by decarboxylation). 
However, biochemical evidences that confirm the direct incorporation of tryptamine as a precursor 
have not been reported [295]. Most, if not all, Chaetonium fungi in the Chaetomiaceae family 
produce L-tryptophan-derived alkaloid, but no P-S reaction-based secondary metabolite has been 
detected [296–298]. 
(2014) A comparative genomic analysis has clarified that C. globosum does have a fungal Pictet-
Spengler (FPS) gene, which remains silent or poorly activated in laboratory cultivations. Therefore, 
a C. globosum IC5I strain was adopted to test for the activation of its “unworking” P-S reaction-
based biosynthetic machinery, and 1-methyl-L-tryptophan (1-MT) was demonstrated to be able to 
up-regulate the FPS expression and condense with the fungal aldehyde flavipin (3,4,5-trihydroxy-6-
methylphthalaldehyde) to unexpectedly form a family of skeletally unprecedented alkaloids 
(Scheme 86), trivially named chaetoglines A–H. Chaetogline B and F have been found to have 
antibacterial activity comparable to that of tinidazole (a coassayed drug prescribed in clinic for 
bacterial infections) against pathogenic anaerobes Veillonella parvula, Bacteroides vulgatus, 
Streptococcus sp., and Peptostreptococcus sp., whereas chaetogline F was also shown to be a potent 
inhibitor of acetyl-cholinesterase (AChE) [299]. 
Figure 5. Piperidine ring-containing secondary etabolites fro a variety of sources.
Fungi, especially the Ascomycota genus, have been reported as prolific producers of alkaloids
containing one or more indole/indoline moieties [291], mostly endowed with potent biological
activities [292]. By time nothing was known regardinf the P-S reaction in the fungal kingdom.
Only more recently the availability of fungal genome sequences has significantly accelerated the
identification of genes involved in the biosynthesis of secondary metabolites from fungi [293,294].
Tang and coworkers revealed that the different strategies to incorporate and derivatize indole
moiety in pathways of fungal alkaloids are based on building blocks, such as L-tryptophan and the
related 4-dimethylallyl-tryptophan (4-DMAT, by prenylation) and trypamine (by decarboxylation).
However, biochemical evidences that confirm the direct incorporation of tryptamine as a precursor
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have not been reported [295]. Most, if not all, Chaetonium fungi in the Chaetomiaceae family
produce L-tryptophan-derived alkaloid, but no P-S reaction-based secondary metabolite has been
detected [296–298].
(2014) A comparative genomic analysis has clarified that C. globosum does have a fungal
Pictet-Spengler (FPS) gene, which remains silent or poorly activated in laboratory cultivations.
Therefore, a C. globosum IC5I strain was adopted to test for the activation of its “unworking”
P-S reaction-based biosynthetic machinery, and 1-methyl-L-tryptophan (1-MT) was demonstrated
to be able to up-regulate the FPS expression and condense with the fungal aldehyde flavipin
(3,4,5-trihydroxy-6-methylphthalaldehyde) to unexpectedly form a family of skeletally unprecedented
alkaloids (Scheme 86), trivially named chaetoglines A–H. Chaetogline B and F have been found to
have antibacterial activity comparable to that of tinidazole (a coassayed drug prescribed in clinic for
bacterial infections) against pathogenic anaerobes Veillonella parvula, Bacteroides vulgatus, Streptococcus
sp., and Peptostreptococcus sp., whereas chaetogline F was also shown to be a potent inhibitor of
acetyl-cholinesterase (AChE) [299].
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Kasanah and coworkers studied the in vitro activity of the β-carboline-containing manzamine
alkaloids against Fusarium solani, Fusarium oxysporum, and Fusarium proliferatum [300]. The data of their
bioassays demonstrated that Fusarium spp were resistant to the manzamine alkaloids, because the fungi
were able to transform manzamines via hydrolysis, reduction, and a retro-Pictet-Spengler. A pathway
that involves the reverse catalytic ring opening and the hydrolysis of the iminium group, namely a
retro-Pictet-Spengler reaction, was proposed for the mechanism of the acid catalyzed epimerization
of reserpine [301]. A retro-P-S pathway was also suggested for the cis to trans epimerization of
1,2,3-trisubstituted-1,2,3,4-tetrahydro-β-carbolines, but it was ruled out on the basis of kinetic data [302].
According to the mechanism proposed for the activity of Fusarium solani on manzamine F, the THBC 278,
provided by reduction of the metabolite 8-hydroxymanzamine A 277 derived from fungal metabolism
of manzamine F, gives by protonation the intermediate 279a, in equilibrium with the open form 279b,
which finally hydrolyzes to the 7-hydroxytryptamine 280 and the aldehyde 281 (Scheme 87) [300].Molecules 2020, 25, x FOR PEER REVIEW 69 of 84 
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7. Conclusions: Drawing a Veil over Act II
In the five years following the centenary birthday of P-S cyclization, a mess of paper demonstrated
that the reaction did not exit the stage, but came up again on the limelight with new features.
In the lustro the chameleonic transformation maintained the role of a protagonist, in spite of a fierce
competition of variant and complementary reactions. But the history of the venerable reaction is not
yet complete fulfilled.
In the same interval (2011–2015), the synthesis of scaffolds other than THIQ and THBC with
potential biological and pharmaceutical application required the use of modified Pictet-Spengler
reactions with structurally different substrates. For instance, in the oxa-Pictet-Spengler cyclization,
that is an oxygen variation of the P-S reaction, an aromatic alcohol component, usually a β-arylethyl
alcohol, reacts with a carbonyl compound (aldehyde, ketone, or their masked derivatives) to
yield polysubstituted isochromans (Scheme 88) [303,304]. Recently a minireview on the catalytic
enantioselective approaches to the oxa-P-S cyclization has been published by Zhu et al. [305].
On the other hand, arylamines linked to an activated aromatic nucleus, such as imidazole, might
be treated with aldehydes to give imidazo-quinoxalines (n = 0) after DDQ oxidation [306] or
triazabenzoazulenes (n = 1) [307] (Scheme 89). Several novel N-rich polycyclic skeletons have
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been synthesized by application of this P-S variation [308–313], for which we propose the name of
aza-Pictet-Spengler. About these presences and more we may talk in the third Act. The curtain falls.
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t
No encore.
As the curtain falls,
All that is waiting is silence.
(Spike Harper)
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